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This dissertation develops novel methodology for three challenging problems in
the estimation of treatment and group effects in the presence of dependently censored
survival data. In Chapter II, we propose semiparametric methods for estimating the
effect of a time-dependent covariate on treatment-free survival. The data structure
of interest consists of a longitudinal sequence of measurements and a potentially cen-
sored survival time. The factor of interest is time-dependent. Treatment-free survival
is of interest and is dependently censored by the receipt of treatment. Patients may
be removed from consideration for treatment, temporarily or permanently. The pro-
posed methods involve landmark analysis and partly conditional hazard regression.
Dependent censoring is overcome through a variant of Inverse Probability of Cen-
soring Weighting (IPCW). The regression parameter of interest is marginal in the
sense that time-varying covariates are taken as fixed at each landmark, with the
modeled mortality hazard function then implicitly averaging across future covariate
trajectories. The proposed methods circumvent the need for explicit modeling of the
longitudinal covariate process.
Mean survival time can be used to quantify both the patient-specific and average
effect of a time-dependent treatment. In Chapter III, we propose semiparamet-
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ric methods for estimating the mean difference between treatment-free and post-
treatment restricted mean lifetime. The data structure of the treatment-free period
consists of a longitudinal sequence of measurements and a potentially censored sur-
vival time, with treatment-free survival dependently censored by the receipt of treat-
ment. Landmark analysis, partly conditional hazard regression, and IPCW are used
to model treatment-free survival. The post-treatment death hazard is modeled using
the measurement history leading up to the treatment time. The average treatment
effect is obtained by averaging over subjects who received treatment, in a manner
which accounts for the independent censoring of treatment times.
In time to event data observed in medical studies, nonproportional hazards and
dependent censoring are common issues when comparing group-specific mortality.
The group effect on mortality may vary over time, as opposed to being constant.
One remedy is adopting a parametric form to model the time-dependent pattern.
However, it is generally difficult to verify the chosen parametric function. Moreover,
in the settings where the proportional hazard assumption fails, investigators tend to
be more interested in cumulative effects on mortality rather than the instantaneous
effect. Estimators using standard approaches are generally biased in the presence of
dependent censoring, which may occur when both censoring and death depend on the
same time-dependent covariates. Therefore, in Chapter IV, we propose an estimator
for the cumulative group effect on survival in the presence of nonproportional hazards
and dependent censoring. The proposed estimator is based on the cumulative hazard
function, assumed to follow a stratified Cox model. No functional form needs to be
assumed for the nature of the nonproportionality.
Each of the proposed methods is shown to be consistent and asymptotically nor-
mal, with consistent covariance estimators provided. Simulation studies reveal that
3
the proposed estimation procedures are appropriate for practical use. We apply
the proposed methods to pre- and post-transplant data on End-stage Liver Disease
patients.
CHAPTER II
Partly Conditional Estimation of the Effect of a
Time-Dependent Factor in the Presence of
Dependent Censoring
2.1 Introduction
Longitudinal and survival data are often observed simultaneously in biomedical
studies. For instance, measurements related to patient health may be collected over
time as a longitudinal process during the course of a patient’s disease, while time
to a failure event (e.g., death) is of chief interest. Information on time-varying
covariates is usually collected at multiple follow-up times through the time to the
event. For example, the number of CD4-lymphocyte counts is frequently employed
as a surrogate marker for HIV; the glomerular filtration rate has been utilized as an
indicator of kidney failure; the Model for End-stage Liver Disease (MELD) score,
(Wiesner et al., 2001) is a very sensitive indicator of liver dysfunction among End-
stage Liver Disease (ESLD) patients. In particular, the liver failure setting is the
motivation for the methods we propose in this report.
In the presence of longitudinal and survival data, it is often of interest to esti-
mate the effect on survival time of a time-dependent factor hypothesized to be an
important indicator for disease progression. One approach to link the time-varying
4
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covariate with the time to event is proportional hazards model (Cox, 1972). To
jointly model survival and longitudinal data, a regression model for the time depen-
dent covariate process is usually adopted. Recent literature includes, for example,
methods proposed by Tsiatis, Degruttola, and Wulfsohn (1995); Henderson, Diggle,
and Dobson (1997); Xu and Zeger (2001); Song, Davidian, and Tsiatis (2002) and
Taylor (2011). In joint modeling, valid inference on the time-to-event component
generally requires that the longitudinal process be modeled accurately. This is diffi-
cult to accomplish in many cases. For example, in practice, one may only measure
the covariate process at discrete times instead of continuously.
Moreover, each of the joint modeling approaches cited in the preceding paragraph
models the death hazard as a function of the covariate at time t. Although these
time-dependent approaches have a long history in survival analysis and are applicable
in many situations, they may not be consistent with the investigator’s objectives in
many practical settings. For example, in the liver failure setting, it is often of interest
to determine which of several patients awaiting liver transplantation will die soonest
in the absence of a transplant; i.e., based on each patient’s history up until that date,
and averaging over the possible scenarios that could occur in the future without a
transplant. An available donor liver is allocated once, meaning that the decision
about which patient is expected to die fastest without a liver transplant would need
to be based on information only up to the date the organ is allocated.
Zheng and Heagerty (2005) proposed a partly conditional model applicable to
some settings like that described in the preceding paragraph. Typically in modeling
survival data, the event time, Di, is from study entry (marking the beginning of
follow-up) to the occurrence of the failure event. In Zheng and Heagerty (2005), it is
duration since measurement time Si, i.e., (Di − Si) that is modeled. The method of
6
Zheng and Heagerty (2005) is referred as “partly conditional” in the sense that the
hazard function being modeled (i.e., that of Di−Si) only conditions on the covariate
history through time Si, rather than the full covariate history. The time-varying
covariate is “frozen” at each measurement time, as opposed to using information on
{t : t > Si}. There would typically be multiple event times for the same subject,
each corresponding to a different measurement time. The authors approach this
element of the data structure through a multivariate survival analysis framework
analogous to Wei, Lin, and Weissfeld (1989). The method does not require modeling
the longitudinal covariate process and there is no imposed dependence structure
between different survival times from the same individual. With respect to related
work, Van Houwelingen (2007) proposed a landmark model based on the partly
conditional method. In this case, the time clock is not reset to zero every time a
measurement is taken.
Each of the partly conditional methods described this far requires that censoring
be independent of death time. However, dependent censoring frequently occurs in
observational studies. A particular case is when survival in the absence of treatment
(hereafter referred to as treatment-free survival) is of interest and both death and
treatment assignment depend on the same time-varying covariates. If the model
being fitted had conditioned on the entire history of the time-dependent covariates,
then independent censoring could be assumed. However, since landmark methods
freeze the time-varying measurement at the landmark time, hence only using part
of the covariate history, dependent censoring can result due to the mutual correla-
tion between future treatment assignment date, treatment-free death hazard, and
the unmodeled portion of the covariate process occurring after the landmark time.
Naturally, dependent censoring can result in greatly biased estimation.
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As stated previously, the data which motivated our current research arise from the
liver failure setting. The preferred method of treatment for liver failure is deceased-
donor liver transplantation. There are thousands more patients awaiting liver trans-
plantation than there are deceased-donor livers. As a result, patients requiring liver
transplantation who are deemed medically suitable are placed on a liver transplant
waiting list. Currently in the United States, the guiding principle in prioritizing
patients for liver transplantation is that patients who are predicted to die the fastest
without a transplant should be given the highest priority for transplantation. Pa-
tients with acute liver disease (known as Status 1 patients) are at the top of the
wait list with highest priority for liver transplantation. They are followed by chronic
liver failure patients, who are sequenced in decreasing order of MELD score. Note
that MELD scores are updated over time, such that MELD is a time dependent
process. In addition, if a patient becomes too sick, then he/she is removed from
the transplant waiting list. Or, inactive status can be issued but possibly canceled
afterward. During an inactive period, the patient is not eligible for transplantation
and will not receive offers of deceased-donor livers. In practice, usually within the
organ arrival day, doctors wish to allocate the donor liver to the patient who will
die soonest without a transplant based on information up until, not beyond that
calendar date. In reality, liver allocation uses updated MELD scores, which is sim-
ilar to our model freezing the covariate. Therefore, although it is clear that liver
transplantation censors pre-transplant death, such censoring amounts to dependent
censoring in the context of a partly conditional model using landmark methods.
Note that, due to dependent censoring and the potential for subjects to become
ineligible for inclusion in the sample, existing methods described previously (includ-
ing existing partly conditional models and landmark methods) cannot be applied
8
directly to liver wait list data. Because the donor organs arrive in calendar time,
it is more natural to choose cross sections based on calendar date as opposed to
follow-up time.
In this report, we propose landmark methods featuring a partly conditional model
to estimate the effect of a time-dependent covariate, in the presence of dependent
censoring. Inverse Probability of Censoring Weighting (IPCW; Robins and Rot-
nitzky, 1992; Robins and Finkelstein, 2000) is used to obtain consistent estimators in
the presence of dependent censoring. To increase precision, we propose two weight
stabilizers that are different than those in the existing IPCW literature. Each land-
mark is based on a common calendar date, not follow-up time, consistent with the
motivating example. At each cross-section (landmark) date, patients who are under
observation (alive, uncensored), untreated, and treatment-eligible are included in the
cross-section. Survival time, with respect to a cross section, is measured from the
landmark date forward; such that the time clock is essentially reset to zero at each
cross section date. We assume that the baseline hazards may differ by cross-section,
such that a stratified Cox model (1972) is appropriate. Instead of modeling the time-
varying covariate process on continuous time, multiple cross sections are chosen over
the observation period to collect measurements from numerous discrete time points.
The proposed methods do not require modeling of the longitudinal process.
The remainder of this article is organized as follows. In Section 2.2, we formu-
late the previously described characteristics of the motivating data structure, then
describe the proposed methods. Asymptotic properties of the proposed estimators
are given in Section 2.3. A simulation study is provided in Section 2.4. Results of
applying the proposed method to the afore-described liver failure data are presented
in Section 2.5. In Section 2.6, we provide some concluding remarks and discussion.
9
Asymptotic derivations are provided in Appendix A.
2.2 Proposed Methods
We begin by setting up the required notation. Let Di be the treatment-free time
to failure for subject i, with i = 1, . . . , n. We assume that Di may be censored
at treatment time, Ti, or independent censoring time, Ci, and therefore we define
the treatment-free observation time as Xi = min(Di, Ti, Ci). We also define the
associated indicators, Δi = I(Xi = Di) and Δ
T
i = I(Xi = Ti), where I(A) = 1 when
condition A is true and 0 otherwise. We define Yi(t) = I(Xi ≥ t). We choose K
cross section times CSk with k = 1, . . . , K, where the cross-section times represent
calendar dates. The {CS1, . . . , CSK} will typically be equally spaced. The number
of cross-sections, K, will generally depend on the length of the study’s observation
period. Let Sik denote the follow-up time of the ith subject on the calendar date of
the kth cross section, CSk. As we describe shortly, we will be modeling survival times
from the cross-section dates, which essentially accounts to re-setting the time clock
to 0 on each cross-section date. Correspondingly, since Di, Ti and Ci are measured
in study time (i.e., time since subject i started follow-up), we then define death,
treatment and censoring times (each measured as time post-cross-section) as follows:
Dik = Di − Sik, Tik = Ti − Sik and Cik = Ci − Sik. Thus Dik, Tik and Cik are the
death, treatment and censoring times, respectively, as measured from the kth cross
section date. Let Ai(t) take value 1 if patient i is eligible to receive treatment as of
follow-up time t, and 0 otherwise.
Figure 2.1 provides a graphical depiction of how each subject’s treatment-free
observation time is transformed into a set of time-since-cross-section dates. Four
subjects are shown (i1, i2, i3, i4) and two cross sections, (k1,k2). The four subjects
10
Note: Vertical dashed lines denote cross-section dates, while horizontal dashed lines denote
treatment-ineligible period. Subject i1 has death times Di1k1 and Di1k2 , corresponding to cross
sections k1 and k2, respectively. Note that, even though subject i1 is not censored after becoming
treatment-ineligible. Subject i2 is treated at time Ti2k2 , and hence censored (perhaps dependently)
at that time, with respect to cross section k2. Subject i3 is not included in either cross section since
i3 starts then finishes follow-up in between cross-sections. Subject i4 first passes cross section k1
and then becomes inactive for a while until a time after cross section k2. Subject i4 is treatment-
ineligible at cross section k2 and, therefore, is not included in this cross section. With respect to
cross section k1, the transplant time Ti4k1 is not censored at the beginning of the treatment-ineligible
period.
Figure 2.1: Examples of the relationship between cross-section time and follow-up
time.
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begin follow-up at times which are staggered in calendar time. Subject i1 has failure
times Di1k1 corresponding to cross section k1 and Di1k2 with respect to cross section
k2. Note that even though subject i1 is deemed treatment-ineligible after cross sec-
tion k2, the subsequent death is not censored. Subject i2 is treated (and therefore
censored) at time Ti2k2 with respect to cross section k2. Subject i3 is not included
in either cross section since i3 starts and then finishes follow-up in between cross-
sections. Subject i4 is included in cross section k1, then becomes treatment-ineligible
for a while until a time after cross section k2. With respect to cross section k1, i4
is censored at treatment time Ti4k1 , as opposed to earlier (at the beginning of the
treatment-ineligible period). Since subject i4 is treatment-ineligible at cross section
k2, i4 is not included in this cross section.
With respect to cross-section k, one observes a vector for subject i, (Xik, Δik, Δ
T
ik),
where Xik = min(Dik, Tik, Cik), Δik = I(Xik = Dik) and Δ
T
ik = I(Xik = Tik).
Note that, for a censored subject, Δik = Δ
T
ik = 0. For ease of presentation, define
Aik = Ai(Sik), an indicator for subject i being treatment-eligible at the time of the
kth cross-section. We now set up a modified version of counting process notation.
In particular, we let Nik(t) = I(Xik ≤ t, Δik = 1)Aik, and write dNik(t) for the
increment Nik{(t+dt)−}−Nik(t). The at risk process is defined as Yik(t) = I(Xik ≥
t)Aik; i.e., in addition to subject i being alive and not treated as of time Sik (i.e.,
that Xi > Sik), to be included in the kth cross section, it is also required that the
subject is treatment-eligible at time Sik (i.e., that Aik = 1). However, if Aik = 1,
subject i is not censored if he/she later becomes inactive at time t > Sik. Thus, being
treatment-eligible at time Sik is a cross-section inclusion criterion, but subsequently
becoming ineligible for treatment is not a censoring criterion. With respect to the
treatment process, we define NTi (t) = I(Xi ≤ t, ΔTi = 1).
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Let Zi(t) denote the covariate vector for subject i at follow-up time t; and let
Zik ≡ Zi(Sik), the covariate vector as measured at the kth cross section date, CSk.
The Zik vector would typically include baseline covariates, such as race and gender,
and time-varying elements as of time Sik. For notational simplicity, we write Zik =
Zi(Sik), although, more generally Zik can be any function of the covariate history





P [t ≤ Dik < t + δ|Dik ≥ t, Zik, Aik = 1].
Note that the t argument pertains to time after the kth cross-section date, with
the covariate “frozen” at its cross-section date value. The objective is to determine
the relationship between the covariate (as known on the kth cross-section date) and
future treatment-free survival time. Since the underlying goal is to determine what
factors are associated with treatment urgency, only subjects who are treatment-
eligible at the kth cross-section date are of interest; hence the conditioning on [Aik =
1].
Death times are modeled using stratified Cox regression,
(2.1) λik(t) = λ0k(t) exp{β ′0Zik},
where the baseline hazards are allowed to be cross-section-specific, although covariate
effects are assumed to be equal across all cross-sections. We make the standard
independent censoring assumption which, in the context of the observed data, is
given by:
λik(t|Z̃i(Sik + t), Aik = 1, Tik > t, Cik > t) = λik(t|Z̃i(Sik + t), Aik = 1),
where Z̃i(Sik + t) = {Zi(s); s ∈ (0, Sik + t)}. However, a model for Dik conditioning
on Zik does not incorporate {Zi(r); r ∈ (Sik, Sik + t)}. Further, it will generally be
13
the case that λik(t) = λik(t|Zik, Aik = 1, Tik > t) due to the correlation between Tik
and Dik resulting from mutual dependence on {Zi(r); r > Sik}.
We use a variant of Inverse Probability of Censoring Weighting (IPCW) to over-
come the dependent censoring of Dik by Tik. The model which takes treatment as
the event is imposed, with hazard function
(2.2) λTi (t) = Ai(t)λ
T
0 (t) exp{θ′0Zi(t)},
where t is the time from study entry. As indicated in equation (2.2), the treatment
hazard is zero at times during which the patient is treatment-ineligible. Therefore,
treatment hazards among eligible patients are assumed to be proportional. The
covariate in model (2.2) is written as Zi(t) for notational convenience. More generally,
the covariate could be any function of the covariate history {Zi(r); r ∈ (0, t)}. The
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p = 0, 1, 2, where, for a vector z, z⊗0 = 1, z⊗1 = z, z⊗2 = zz′. The Breslow estimator
of ΛT0 (t) is given by Λ̂
T









The IPCW method allows us to obtain consistent estimators by weighting each
subject’s experience by the inverse of (what can be thought of heuristically as) the
probability of remaining untreated. In particular, the covariate effect, β0, can be
estimated as the root of the stratified inverse-weighted score function,







Aik{Zik − Zk(t; β, W )}W Aik(t)dNik(t),
where τk satisfies P (Xik ≥ τk) > 0, and the weight function is given by W Aik(t) =











′Zik) for p = 0, 1, 2. We refer to
W Aik(t) as the Type A weight. Typically, τk is set to the largest observation time
from the kth cross section.
With some algebra, dNik(t) in (2.3) can be replaced by dMik(t) = dNik(t) −
Yik(t)dΛik(t), such that the score function can also be written as







Aik{Zik − Zk(t; β, W )}W Aik(t)dMik(t).
A consistent estimator of β0 should satisfy E[W
A
ik(t)dMik(t)|Zik] = 0. We can write




ik(t) = I(Dik ≥ t)[dN∗ik(t) −
dΛik(t)] and N
∗
ik(t) = I(Dik ≤ t). Under the assumed model, E[dM∗ik(t)|Zik] =
0, which leads to E[I(Cik > t)dM
∗
ik(t)|Zik] = 0 in the case of independent cen-
soring. In the presence of dependent censoring, without the IPCW term W Aik(t),
E[dMik(t)|Zik] = 0 since E[dMik(t)|Zik] = E[I(Tik > t)I(Cik > t)|Zik]E[dM∗ik(t)|Zik].
However, it can be shown that
E[W Aik(t)dMik(t)|Zik]
= E[E[W Aik(t)dMik(t)|Zik, Zi(Sik + t)]|Zik]
= E
[
E[I(Ti > Sik + t|Ti > Sik)]
exp{−ΛTi (Sik + t) + ΛTi (Sik)}
E[I(Cik > t)dM
∗
ik(t)|Zik, Zi(Sik + t)]
∣∣∣∣Zik]
= E[E[I(Cik > t)dM
∗
ik(t)|Zik, Zi(Sik + t)]|Zik]
= E[I(Cik > t)dM
∗
ik(t)|Zik] = 0,
such that the weighted score function, (2.3), has mean 0.
However, in practice, some values of W Aik(t) could be very large due to large values
of ΛTi (t). As a result, such unstable weights could lead to imprecise estimation of
β0. Similar to Robins and Finkelstein (2000) and Miloslavsky et al. (2004), to make
the estimator more precise, a stabilizer is incorporated into the weight function. We
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explore two versions of the stabilized weight. The first, which we refer to as the Type
B weight, is given by
(2.4) W Bik (t) = Yik(t)
exp{ΛTi (Sik + t)}
exp{ΛTi (Sik)} exp{ΛTik(t)}
,
where ΛTik(t) is the cumulative hazard from a proportional hazard model which takes
transplant as the event, λTik(t) = λ
T
0k(t) exp{θ′1Zik} and t is the time from entry of
study with θ1 as covariate effect. For the Type B weight, the time intervals covered
by stabilizer and Type A estimator are the same, such that W Bik (t) may serve to
reduce the variability in the estimator of β0. Another weight we evaluate is more
intuitive and yields the Type C weight,
(2.5) W Cik(t) = Yik(t) exp{ΛTi (Sik + t)},
which tracks the history from entry to study up to time t, without conditioning on
the fact that Ti > Sik. Since the stabilizing components of both W
B
ik (t) and W
C
ik (t)
only based on the covariate history up to the kth cross section time, {Zik}, it can be
shown that E[W Bik (t)dMik(t)|Zik] = 0 and E[W Cik (t)dMik(t)|Zik] = 0, such that the
weighted score function (2.3) still has mean 0.
2.3 Asymptotic Properties
We assume that the random vectors {Xi, Δi, ΔTi , Z̃i(Xi), Ãi(Xi)}, for i = 1 . . . n,
are independent and identically distributed, with Zi(t) bounded for t ∈ (0, τ ], where
τ satisfies P (Xi ≥ τ) > 0. We summarize the asymptotic properties of the proposed
methods in the following theorem. The regularity conditions are listed in Appendix
A.
Theorem II.1. Under certain regularity conditions, n1/2(β̂ − β0) converges asymp-
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dMTi (t) = dN
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′Zik)], p = 0, 1, 2,
r
(p)
T (t; θ) = E[Yi(t)Zi(t)
⊗p exp{θ′Zi(t)}], p = 0, 1, 2,
with Ω(β), H(t; β, W ), ΩT (θ), U
T
i (θ) and G(t1, t2; β) defined in Appendix A.




i, where ϕ̂i is ob-
tained by replacing all limiting values in ϕi by their empirical counterparts. A proof
of Theorem II.1 is provided in Appendix A. The proof proceeds by demonstrating
that, asymptotically, n1/2(β̂ − β0) = n−1/2
∑n
i=1 ϕi + op(1) through a sequence of
Taylor series expansions.
The proof is given for the Type A weight, W Aik(t) = Yik(t) exp{ΛTi (Sik + t) −
ΛTi (Sik)}. In practice, a stabilized version would usually be preferred. As implied
by Theorem II.1, the computation of the variance is quite complicated, and is more
complicated with the Type B weight. Such considerations motivate a computation-
ally simpler form for the variance estimator. That is, to take the weight W Aik(t), or
W Bik (t) or W
C















{Zik − Zk(t; β̂, Ŵ )}Ŵik(t)dM̂ik(t).(2.6)
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This simplified variance estimator can be calculated using Cox regression software
that allows weights and a robust variance estimator; e.g., proc phreg in SAS, coxph
in R.
2.4 Simulation
We modify the algorithm developed by Zheng and Heagerty (2005) to gener-
ate data which follow a partly conditional proportional hazards model. We first
generate a binary treatment group indicator, Zia, taking values 0 and 1 with prob-
ability 0.5. A longitudinal marker Zi(Sik) measured at a common set of cross sec-
tion dates CS1, CS2, . . . , CSK is constructed. To generate data [Di, Zia, Zib] where
Zib = vec{Zi(Sik)}, we first create Zib0 = bi +
∑K
k=1 log(Vik)/γ2, where bi ∼ N(μ, σ2)
and Vik ∼ P (ρ), independent positive stable random variables with index ρ (Samor-
idnitsky and Taqqu, 1994). A pre-treatment death time Di, is then generated with
hazard λi(t) = V
1/ρ
i0 λ0(t) exp{γ1Zia + γ2Zib0}, where Vi0 ∼ P (ρ) and is independent
of Vik, with Λ0(t) = (t/a)
1/ρ2 and a is a constant. Let Zi(Sik) = Zib0 − log(Vik)/γ2.
Then the death hazard can be written as
λi(t) = V
1/ρ
i0 λ0(t) exp{γ1Zia + γ2Zi(Sik) + log(Vik)}.(2.7)
Subject i enters the study on calendar date Li, where Li is a Uniform(0, b)
variate. Treatment time, Ti, is generated from the proportional hazards model,
λTi (t) = λ
T
0 (t) exp{θ01Zia + θ02I(t > Ri)},(2.8)
where λT0 (t) = d3, θ0 = (θ01, θ02), and Ri is time of treatment-ineligibility which is
generated with hazard λRi (t) = λ
R
0 (t) exp{d1Vi0}, with λR0 (t) = 1/d2. Thus, Ri and
Di are positively correlated, which is a reflection of the data which motivated the
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proposed methods. Note that treatment time and pre-treatment death time, Ti, and
Di, are dependent since both depend on time of treatment ineligibility Ri.
To see that the prescribed set-up yields proportional hazards, integrating both
sides of model (2.7), gives
Λi(t) = V
1/ρ
i0 Λ0(t) exp{γ1Zia + γ2Zi(Sik)}Vik,
such that the pre-treatment survival function is given by
exp[−Λi(t)] = exp[−Λ0(t) exp{γ1Zia + γ2Zi(Sik)}VikV 1/ρi0 ].
Transforming the time scale to reflect time since cross section, define tk = t − Sik.
Then, take the expectation with respect to Vik first and using the properties of the
positive stable distribution, we have
exp[−Λi(tk|Zia, Zi(Sik), Di > Sik, Vi0)] = exp[−(Λ0(t) exp{γ1Zia+γ2Zi(Sik)}V 1/ρi0 )ρ/ cos(πρ/2)].
Then, taking the expectation with respect to Vi0, we have
exp[−Λi(tk|Zia, Zi(Sik), Di > Sik)] = exp[−(Λ0(t)ρ2 exp{ρ2γ1Zia+ρ2γ2Zi(Sik)}/ cos(πρ/2)(ρ+1)],
which implies the following equation after taking logarithm and negative of both
sides
Λi(tk|Zia, Zi(Sik), Di > Sik) = Λ0(t)ρ2 exp{ρ2γ1Zia + ρ2γ2Zi(Sik)}/ cos(πρ/2)(ρ+1).
Differentiating with respect to tk,




Using this construction, the hazard for Dik = Di − Sik will generally depend
on Sik and therefore stratified models similar to those considered by (Wei, Lin, and
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Weissfeld, 1989) would be appropriate. With Λ0(t) = (t/a)
1/ρ2 , λ0(tk+Sik)ρ
2{Λ0(tk+
Sik)}(ρ2−1) = 1/a, we obtain
λi(tk|Zia, Zi(Sik), Di > Sik) = exp{ρ2γ1Zia + ρ2γ2Zi(Sik)}/[a cos(πρ/2)(ρ+1)].
If we define λik(t; Sik) = λi(tk|Zia, Zi(Sik), Di > Sik), λ0k(t) = [a cos(πρ/2)(ρ+1)]−1
and β0 = (β01, β02) = (ρ
2γ1, ρ
2γ2), then the proportional hazard model on treatment-
free survival is achieved,
λik(t; Sik) = λ0k(t) exp{β01Zia + β02Zi(Sik)}.(2.9)
After generating the data, we only include for analysis those Zi(Sik) with Li <
Sik < min(Xi, Ri). Data pertaining to survival time since cross section {Xik, Δik, Zia, Zi(Sik)}
is used to fit model (2.9), with time to transplant data {Xi, ΔTi , Zia, Zi(t)} used to
fit model (2.8).
We evaluate samples with n = 1000 subjects and obtain 10%, 20%, and 40%
censoring by varying a from 104 to 4 × 107. The value of d2 varies from 300 to
3000, resulting in ineligibility rates from 10% to 30%. There are K = 10 cross
section dates. We set b = 500, [θ01, θ02] = [−1,−1], μ = 18, σ = 1, [γ1, γ2] =
[−1,−0.5], [−0.5,−0.25], [0, 0], d1 = d3 = 0.001, with CSk = 100 × k. For all our
simulated situations, 1000 Monte Carlo data sets are used. We present results using
ρ = 0.8, thus [β01, β02] = [−0.64,−0.32] when [γ1, γ2] = [−1,−0.5]. With number of
cross sections set to K = 10, the average number of cross sections per subject is 0.7
to 2.4, depending on the censoring level. We apply the simplified variance estimate
which treats the estimated weights as fixed; i.e., as given in (2.6).
Table 2.1 presents simulation results based on Type A weight, while Tables 2.2
and 2.3 present results for Type B and Type C, respectively. Estimates of β0 appear
to be consistent based on all weights. The variance of the Type B estimator is smaller
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than that of Type A, which is likely the result of the added stabilizer. Coverage prob-
abilities using the proposed (simplified) variance estimator are close to the nominal
95% level, with those of the Type B estimator being slightly higher than those of
Type A. It appears that the variance of the Type C estimator is greater than that of
Type A. This could result from the noise added by incorporating history before the
cross section time in W Cik(t). The added piece covers a different time interval and
thus does not actually function as a stabilizer. Coverage probabilities for the Type
C estimator are slightly lower than those of Type A.
2.5 Application
We applied the proposed methods in order to compare pre-transplant mortality
between acute and chronic End-Stage Liver Disease (ESLD). The study population
included patients initially wait listed for deceased-donor liver transplantation be-
tween March 1, 2002 and December 31, 2009 in United States. Data were obtained
from the Scientific Registry of Transplant Recipients (SRTR), a national, population
based organ transplant registry. Only patients age ≥ 18 at listing and not previously
transplanted (i.e., not repeat transplant candidates) were included in the study popu-
lation. Cross-section dates were chosen every 7 days from 03/01/2002 to 12/31/2009,
such that there were K = 409 cross sections in all. At any given cross section date,
any subject who was still on the wait-list (not inactive and not removed) was in-
cluded in the cross section since, in practice, patients who got removed or were made
inactive were no longer eligible to receive offers for deceased-donor livers. Given the
objectives of our analysis, it is appropriate to compare only patients who, in a given
cross-section date, are in fact eligible to receive a liver transplant. However, after



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































subsequently deactivated or removed from the wait-list. Deactivation and removal
(and the associated death that may follow) are potential consequences of not receiv-
ing a liver transplant. For the death model, the failure time was defined from date of
cross section to the date of death, transplant or censoring whichever occurred first.
In order to construct the IPCW weight, ΛTi (t) was estimated based on a time-
dependent Cox model in which transplant was the event. For the time-to-transplant
model, time t starts from the beginning of the follow-up (the date of wait listing), as




where the subscript r = 1, . . . , 11 stands for region. The presence of the indicator,
Ai(t), reflects the fact that a patient’s time while inactive or removed does not con-
tribute to the estimation of θ0 or Λ
T
0r(t). The patient level covariate, Zi(t), included
MELD score, Status 1, albumin, age, gender, race, diagnosis of Hepatitis C, body
mass index, diabetes, hospitalization, blood type, dialysis within prior week, en-
cephalopathy, ascites and serum creatinine. We evaluated several different versions
of weight, including Wikr(t) = Yikr(t) (unweighted), W
A
ikr(t) = Yikr(t) exp{ΛTikr(t +
Sik)−ΛTikr(Sik)}, W Bikr(t) and W Cikr(t). Even for the stabilized weight, some very large
values occurred. Since we found that 99% of weights were less than 10, weights were
then capped at 10.
The model of primary interest, the pre-transplant death model, was also stratified
λikr(t) = λ0kr(t) exp{β ′0Zik},
where the subscript r = 1, . . . , 11 stands for region and k = 1, . . . , 409 stands for cross
section. The subject level covariates at cross section k, Zik, included MELD score (21-
23, 24-26, 27-29, 30-32, 33-35, 36-40), Status 1 (as the reference, to which all MELD
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Table 2.4: Analysis of liver wait-list mortality (using Type B Weight)
Group β̂ ŜE(β̂) eβ̂ p-value
Status 1 0 . 1 .
MELD 21-23 0.05 0.267 1.05 0.87
MELD 24-26 0.18 0.272 1.20 0.50
MELD 27-29 0.52 0.276 1.68 0.06
MELD 30-32 0.25 0.334 1.29 0.45
MELD 33-35 0.96 0.301 2.62 0.001
MELD 36-40 0.95 0.306 2.58 0.002
categories are compared), albumin, age, gender, race, diagnosis, body mass index,
diabetes, hospitalization status at listing and previous malignancy. Also included in
Zik were average change in MELD score (pertaining to the time interval between the
date of listing and cross-section k date, and estimated using ordinary least squares)
and average change in albumin (estimated analogously). Other elements included
the percentage of time spent in inactive status, and percent of time receiving dialysis.
Since 99% of MELD and albumin slope values before cross sections fell in the [-1,1]
interval, the slopes were bounded by -1 and 1.
We focused on comparing each MELD category > 20 with Status 1 (reference).
Our final sample consisted of n = 23, 657 patients.
Results based on the Type B weight are listed in Table 2.4. MELD group 33-35
has a partly conditional pre-transplant death hazard of 2.62 (p = 0.001) times that
of Status 1; the corresponding hazard ratio for MELD 36-40 is 2.58 (p = 0.002).
Both unweighted and weighted results are listed in Table 2.5. After weighting the
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Table 2.5: Analysis of liver wait-list mortality; Comparison of results using different
weight.
Unweighted Type C Weight Type A Weight Type B Weight
Group β̂ ŜE(β̂) β̂ ŜE(β̂) β̂ ŜE(β̂) β̂ ŜE(β̂)
Status 1 0 . 0 . 0 . 0 .
MELD 21-23 -0.81 0.210 0.01 0.271 0.07 0.270 0.05 0.267
MELD 24-26 -0.75 0.215 -0.002 0.286 0.11 0.281 0.18 0.272
MELD 27-29 -0.29 0.220 0.31 0.287 0.42 0.283 0.52 0.276
MELD 30-32 -0.32 0.256 0.10 0.348 0.11 0.339 0.25 0.334
MELD 33-35 0.26 0.246 0.91 0.345 0.92 0.321 0.96 0.301
MELD 36-40 0.33 0.272 0.79 0.335 0.73 0.324 0.95 0.306
model, the parameter estimates of MELD group became larger, in each case. Similar
to the findings from simulation studies, the standard errors in Table 2.5 were the
lowest for the Type B weight, while those for Type C were the largest.
It is interesting that MELD (i.e., chronic liver disease) patients had higher mor-
tality than Status 1 (i.e., acute liver disease) patients, both from a clinical and from
a public health perspective. Supplementary analysis revealed that if only based on
cross section status, acute patients died very fast in the early stage, i.e., the Status
1 Kaplan-Meier curves dropped more quickly than MELD groups. However, Status




In this chapter, we propose semiparametric methods to estimate the effect of
a time dependent covariate in the presence of a possibly censored survival time.
Treatment-free survival is of our interest, and pre-treatment death may be depen-
dently censored by receipt of treatment. Subjects can also experience permanent or
temporary periods of ineligibility for receiving treatment. Landmark analysis with
a partly conditional hazard model are combined in the proposed methods. Multiple
cross-section dates are chosen, with subjects included in the sample corresponding to
a cross-section if they are alive uncensored, treatment-free, and treatment-eligible.
Survival time is measured from a given cross-section date forward, rather than from
the start of follow-up. Covariates values are “frozen” at cross-section dates and not
updated afterward, which is the reason why the method is called partly conditional.
However, fixing the covariate values on cross-section dates results in dependent cen-
soring, since death and treatment times are independent only if conditioning on the
whole time-dependent covariate history. A modified version of Inverse Probability
of Censoring produces consistent estimators in the presence of dependent censoring.
Stabilized versions of the weights are used to estimate the covariate effect more pre-
cisely. The same subject could have multiple survival times with respect to different
cross-section dates, and no specific covariance structure is imposed for such times.
A stratified IPCW weighted proportional hazards model is applied with each cross-
section date data serving as a stratum. The proposed methods circumvent modeling
of the longitudinal covariate process explicitly. The model is in part marginal, since
fixing time-varying covariate values at cross-section dates could be seen as averaging
mortality hazard function implicitly across future covariate trajectories. The pro-
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posed estimators are demonstrated to be consistent and asymptotically normal, with
consistent covariance estimators provided. Through simulation studies, the proposed
estimator is revealed to be appropriate for practical use. We applied the proposed
methods to wait-list mortality among end-stage liver disease patients.
Zheng and Heagerty (2005) proposed partly conditional Cox regression meth-
ods. Van Houwelingen (2007) proposed landmark models based on partly condi-
tional methods. In Zheng and Heagerty (2005), the time clock is re-set at covariate
measurement times, unlike our methods, wherein the clock is re-set at cross-section
dates. Neither the Zheng and Heagerty (2005) or Van Houwelingen (2007) methods
deal with dependent censoring or accommodate treatment ineligibility.
Comparisons of pre-transplant death rates between Status 1 and MELD patients
have rarely been conducted previously; largely because the assumption that Status
1 patients have the highest death rate is widely accepted by the liver transplant
community. However, in a recent study using a traditional time-dependent model,
death rates of high-MELD patients were shown to be comparable to those of Status
1. Specifically, (Sharma et al., 2012) compared the mortality of Status 1 and high-
MELD patients using a time-dependent model to ESLD patients and a 14-day follow-
up period. The most important result of their study was that MELD≥ 40 patients
have higher pre-transplant mortality than Status 1 patients. Results of our proposed
methods show that MELD ≥ 33 is associated with significantly higher pre-transplant
mortality than Status 1. Unlike traditional time-dependent models, the proposed
method compares the mortality from a given cross-section date forward; inspired by
the real-world situation in which an organ arrives (on a given calendar date) and one
wishes to identify which patient would die next in the absence of liver transplantation,
using only information up until that particular calendar date.
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The methods in this paper are of easy implementation and computation. Multiple
landmarks are chosen to make use of the data more fully. Too few cross sections will
lead imprecision, while too many cross-sections may lead to computation difficulties.
Sampling cross section dates or sampling subjects within each cross section may
be one solution. Another problem is non-proportional hazards, in which case the
ratio of cumulative hazards or the difference in restricted mean life time are possible
measures by which to summarize the cumulative effect. Extensions of the proposed
methods to estimate such quantities would be quite useful.
CHAPTER III
Estimating Average Treatment Effects on Mean
Survival Time when Treatment is Time-dependent
and Censoring is Dependent
3.1 Introduction
In clinical settings, subjects often begin follow-up untreated, with some going
to receive the treatment at some time in the future. In various settings, patients
may experience treatment ineligibility, temporarily or permanently. In the setting
of our interest, receiving treatment is time-dependent, not randomized and depends
on time-varying covariates for which serial data are measured. As a result, joint
data on the longitudinal covariate and possibly censored survival time are observed
simultaneously. The effect of the time-dependent treatment is of interest and could
be quantified through mean survival time, which is easy to interpret and needs no
assumption on the shape of survival curves, such as proportionality in the context of
(Cox, 1972) model. Due of finite duration of study and unclosed survival curves, it is
more practical to use restricted mean life time, which is the area under the survival
curve from 0 up to a specific time L, as opposed to infinity.
When approached through a joint modeling approach, valid inference on the
time-to-event component generally requires the longitudinal process be accurately
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modeled, which is often very difficult to achieve. Zheng and Heagerty (2005) pro-
posed a partly conditional model, in which the duration since measurement time
Si, (Di − Si) is modeled, rather than the event time Di from study entry. The
time-varying covariate value is then “frozen” at time Si. The resulting model is
referred to as “partly conditional” since the hazard function only conditions on the
covariate history on measurement up to time Si, as opposed to the full information
which includes covariate values for {t : t > Si}. Therefore, rather than modeling
the time-varying covariate explicitly to predict future covariate values, the partly
conditional model implicitly averages over the possible paths. However, adjusting
for only part of the covariate history causes treatment initiation to be dependent
censoring for treatment-free death. Consistent estimation for parameters pertaining
to the treatment-free death hazard can be obtained through Inverse Probability of
Censoring Weighting (IPCW), proposed originally by Robins and Rotnitzky (1992);
see also Robins and Finkelstein (2000). The IPCW method aims to essentially create
pseudo-data free of dependent censoring through weighting. Of our chief interest, the
average effect of treatment on the treated, is a weighted average of subject-specific
treatment effect estimates, with each observed treatment weighted by inverse of the
probability of remaining uncensored (Horvitz and Thompson, 1952).
The motivation of our research is the liver transplant setting. The number of
available deceased-donor livers is always less than the number of patients awaiting
liver transplantation. As a result, patients who are medically suitable are placed on a
deceased-donor liver transplant waiting list. Patients typically begin follow-up on the
wait list (untreated), such that transplantation is a time-dependent treatment. At
the top of the list are acute liver disease (Status 1) patients, followed by chronic liver
failure patients sequenced in decreasing order of Model for End-Stage Liver Disease
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(MELD) score, a very strong predictor of pre-transplant mortality. Transplantation
results in dependent censoring to pre-transplant death since MELD scores predict
both wait list mortality and transplant rates. Note that patients may be removed
from the wait list, or made inactive and, in such cases, are per permanently or
temporarily ineligible to receive a transplant.
Various methods in the causal inference literature have estimated the average
causal effect through the hazard ratio based on a marginal structural model (e.g.,
Hernan, Brumback, and Robins, 2000, 2001; Robins, Hernan, and Brumback, 2000).
Other authors estimated treatment effect via restricted mean survival time (Chen
and Tsiatis, 2001; Schaubel and Wei, 2011; Zhang and Schaubel, 2010). But very few
methods have contrasted pre- and post-treatment mean survival time when treatment
is time-dependent. Due to the complexity caused by the time-dependent treatment,
the potential for patients to become ineligible for treatment consideration and depen-
dent censoring, the afore-mentioned methods cannot be applied to our motivating
data directly. Schaubel et al. (2009) proposed methods for estimating pre-treatment
restricted mean lifetime. Of chief interest was the application to national liver failure
data. Specifically, a patient-specific score was developed to replace the MELD score
as the basis for ranking wait-listed patients. The focus of this work was on the fitted
values. Asymptotic properties were not developed, nor were simulations conducted.
Moreover, methods for estimating the average treatment effect were not proposed.
In this article, we propose methods for estimating the average effect on the treated
of a time-dependent treatment by taking an appropriately weighted average of esti-
mated subject-specific differences between restricted mean survival time, post- ver-
sus pre-treatment. In particular, for each observed treatment time, we project out
a predicted post-treatment survival curve based on parameter estimates from post-
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treatment survival model, which conditions on measurement history leading up to the
treatment time. We also project a treatment-free survival curve, using fitted values
from the cross-section-based partly conditional treatment-free survival model, which
is analogous to the methods from Chapter II. Then, the areas under the survival
curves up to a pre-specified truncation time (e.g., 5 years) represent the restricted
mean lifetime estimates. The difference between post- and pre-treatment restricted
mean lifetimes represent the subject level treatment effect estimate, and is computed
for each observed treatment. At last, we then weight each observed treatment by the
probability of remaining uncensored. This average is taken using normalized weights
by IPCW (based on a model for independent censoring), such that the weighted
time-until-transplant distribution represents that which would have been observed
in the absence of independent censoring.
The remainder of this article is organized as follows. In Section 3.2, we set up the
notation and describe the proposed methods. Asymptotic properties of the proposed
estimators are listed in Section 3.3. A simulation study is provided in Section 3.4.
Results of applying proposed methods to data obtained from the Scientific Registry
of Transplant Recipients (SRTR) will be given in Section 3.5. Discussion is provided
in Section 3.6. Details regarding the asymptotic derivations are given in Appendix
B.
3.2 Proposed Methods
First, we define the necessary notation. Let Di be the death time for subject i,
with i = 1, . . . , n. We set Ti to be the treatment time for subject i. It is possible
that Di and/or Ti may not be observed due to independent censoring at time Ci.
Observation time is then given by Xi = Di ∧ Ci, where a ∧ b = min(a, b). Subjects
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begin follow-up untreated, with some going to receive treatment unless they die first.
We define the observed data counting processes for death, censoring, and treat-
ment as Ni(t) = I(Di ≤ t, Di < Ci), NCi (t) = I(Ci ≤ t, Ci < Di), and NTi (t) =
I(Ti ≤ t, Ti < Di ∧ Ci) respectively. The covariate vector Zi(t) contains both time-
independent and time-dependent factors and perhaps some functions of t such as
(t, t2, t3). The covariate history on (0, t] is defined as Z̃i(t) = {Zi(u); u ∈ (0, t]}. The
indicator for treatment eligibility is defined as Ai(t) which equals 1 when the ith
subject qualifies for the treatment as of follow-up time t and 0 otherwise. Treatment
eligibility history is represented by Ãi(t) = {Ai(u); u ∈ (0, t]}. Let D0i be the death
time for subject if treatment were unavailable. Consider a subject treated at time Ti,
and define the death time in the presence of treatment as D1i . For a treated subject,
the death time is necessarily post-treatment and the post-treatment survival time
(since treatment) is given by D1i −Ti. It is useful to consider when the treated subject
would have died had, in fact, treatment not been received, and we denote this time
by D0i − Ti.
Suppose that treatment is assigned in calendar time. On any given day, we can
consider the benefit of assigning treatment to specific patients. In particular, it would
be useful to predict the patient’s prognosis survival from that day forward, under
two cases: (0) the subject does not receive treatment ever (1) the subject receives
treatment starting that day. Then the difference between two survival predictions
can be used to quantify the benefit of treatment.
Examining this setting more formally, suppose that patient i is being considered
for treatment on a given calendar date. On that calendar date, the subject has
previous follow-up time of Si time units. As stated previously, only subjects who are
alive and treatment eligible are going to receive the treatment. Suppose that subject
35
i has covariate Zi(Si) and is eligible; i.e., {Ai(Si) = 1, Di > Si, Zi(Si)}. Of interest
are both the restricted mean (residual) lifetime if subject i is treated at time Si,
μi1(Si) = E[{D1i − Si} ∧ L|Di > Si, Ai(Si) = 1, Zi(Si), Ti = Si],
versus the corresponding mean residual lifetime if the subject remained untreated,
μi0(Si) = E[{D0i − Si} ∧ L|Di > Si, Ai(Si) = 1, Zi(Si)].
The treatment effect is then defined as,
Δi(Si) = μi1(Si) − μi0(Si).
Note that L is some specific length of time chosen in light of the available follow-up
time. The arguments of μij(·), with j = 0, 1, and Δi(·) reflect that a specific follow-
up time, Si, and covariate vector, Zi(Si), are being considered. Thus subject specific
treatment effects, Δi(Si), is predicted via μi1(Si) and μi0(Si).
The overall treatment effect could be measured by averaging over the subject level
estimate, Δ = E[Δi(Si)], where the expectation is with respect to {T, Z(T )}, the
joint distribution of treatment time and covariate vector (at the time of treatment)
among treated patients.
Instead of estimating the pertinent means directly, the following hazard functions
are modeled,




P{t ≤ Di−Si < t+ δ|Di−Si ≥ t, Ai(Si) = 1, Zi(Si), dNTi (Si) = 1},










λij(t; Si)dt}du. Note that the conditioning specifically
on Ai(Si) and Zi(Si) is for ease of presentation. More generally, one could condition
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on Ãi(Si) and Z̃i(Si), the treatment-eligibility and covariate histories, respectively,
if the application at hand required.
Note that the just-defined hazard functions are assumed to be independent of
the actual receipt of treatment; i.e., λij(t; Si|{NTi (u); u ≥ Si}) = λij(t; Si). This
no-unmeasured-confounders assumption is required in order to consistently estimate
the quantities of interest via observed data. The observed-data version of the hazard
function is given by λi(t; Si) = λi1(t; Si)dN
T
i (Si) + λi0(t; Si){1 − NTi (Si + t)}. We
assume that Ci is independent censoring in the sense that λi(t; Si) = λi(t; Si|Ci >
Si + t) and that Ti is also independently censored by Ci. With these assumptions,
λi1(t; Si) = λi1(t; Si|dNTi (Si) = 1), which implies that one can validly model the
post-treatment hazards, using only the observed treatments.
We now turn our attention to the model for λi0(t; Si). Since the hazard func-
tion explicitly conditions on Zi(Si), and since {Zi(u); u > Si} may affect both the
treatment-free death hazard and the treatment hazard at time {u > Si}, treatment-
free death is dependently censored by Ti. We overcome this issue using IPCW, which
requires a model for
λTi (t; Zi(t)) = lim
δ↓0
δ−1P{t ≤ Ti < t + δ|Di ∧ Ti ≥ t, Ai(t), Zi(t)}.
Note that the conditioning is on Zi(t) and Ai(t) instead of Zi(Si) and Ai(Si). The
treatment time hazard is assumed to follow a time-dependent model, with time axis
t (follow-up time) as opposed to time since cross section Si. We also assume that
λTi (t) = λ
T
i (t; Zi(t), Di), which allows estimation of λi0(t; Si) based on pre-transplant
data in the presence dependent censoring at Ti through IPCW.
We assume the following proportional hazards models for pre- and post-treatment
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respectively,
λij(t; Si) = λ0j(t) exp{β ′jZi(Si)}, j = 0, 1,
where λ0j(t), are unspecified baseline hazards, βj are unknown regression coefficients;
and j = 0 is with respect to pre-transplant and j = 1 refers to post-treatment.
We now describe how to fit the pre-treatment death model,
λi0(t; Si) = λ00(t) exp{β ′0Zi(Si)}.
We choose K calendar date based cross-section times CSk with k = 1, . . . , K. The
{CS1, . . . , CSK} can be equally spaced; but, this is not required. Suppose Sik is the
follow-up time for the ith patient at the kth cross-section date, CSk. Since we will
model the survival time since cross-section, the time clock is essentially reset to 0
at each cross section date. Subject i is included in the cross-section sample at CSk
if alive, untreated, uncensored and treatment-eligible; i.e., if Ti ∧ Ci ∧ Di > Sik and
Ai(Sik) = 1. Since survival time from cross-section is modeled, define Dik = Di−Sik,
Tik = Ti − Sik and Cik = Ci − Sik as the death, transplant and censoring time
respectively corresponding to the ith patient and measured from the kth cross section
date. A modified counting process is also defined, where Ni0k(t) = Ni(Sik + t)I(Ti >
Sik + t) with increment dNi0k(t) as Ni0k{(t + dt)−} − Ni0k(t). The pertinent at-risk
process is given as Yi0k(t) = Yi(Sik + t)I(Ti > Sik + t). To simplify the notation, we
define Aik = Ai(Sik), Zi0k = Zi(Sik) and Zi0k(t) = Zi(Sik + t).
Figure 3.1 provides an illustration of how the treatment-free observation time is
transformed into time-since-cross-section times. Four subjects (i1, i2, i3, i4) and two
cross sections (k1,k2) are shown. The four subjects begin follow-up at different calen-
dar time. For subject i1, failure times Di1k1 corresponds to cross section k1 and Di1k2
refers to cross section k2. Note subject i1 is not censored at the treatment-ineligible
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Note: Vertical dashed lines denote cross-section dates, while horizontal dashed lines denote
treatment-ineligible period. Subject i1 has death times Di1k1 and Di1k2 , corresponding to cross
sections k1 and k2, respectively. Note that, even though subject i1 is not censored after becoming
treatment-ineligible. Subject i2 is treated at time Ti2k2 , and hence censored (perhaps dependently)
at that time, with respect to cross section k2. Subject i3 is not included in either cross section since
i3 starts then finishes follow-up in between cross-sections. Subject i4 first passes cross section k1
and then becomes inactive for a while until a time after cross section k2. Subject i4 is treatment-
ineligible at cross section k2 and, therefore, is not included in this cross section. With respect to
cross section k1, the transplant time Ti4k1 is not censored at the beginning of the treatment-ineligible
period.
Figure 3.1: Examples of the relationship between cross-section time and follow-up
time.
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time after cross section k2. Subject i2 is treated, and dependently censored at time
Ti2k2 since cross section k2. Subject i3 is not included in either cross section due to
late start and early finish of the follow-up within between two cross-sections. Sub-
ject i4 is included in cross section k1, but becomes and remains treatment-ineligible
until a time after cross section k2. With respect to cross section k1, i4 is censored
at treatment time Ti4k1 , as opposed to being censored earlier at the beginning of the
treatment-ineligible period. Since subject i4 is treatment-ineligible at cross section
k2, i4 is not included in this cross section.
We will estimate β0 through a stratified model,
λi0k(t; Si) = λ00k(t) exp{β ′0Zi0k},
where λ00k(t) are the cross-section-specific baseline hazards. The (overall) baseline
hazard function of interest will be estimated by appropriately averaging the cross
section specific λ00k(t) estimators, as will be described later.
As discussed previously, we require a model for the treatment hazard,




P{t ≤ Ti < t + δ|Ti ≥ t, Ai(t), Zi(t)},
in order to carry out IPCW for the pre-treatment experience. The following propor-
tional hazards model is assumed,
λTi (t) = Ai(t)λ
T
0 (t) exp{θ′0Zi(t)},
where t is the time from entry to the study. Define the treatment counting process
NTi (t) = I(Ti ≤ t ∧Xi) and its corresponding increment dNTi (t) = NTi {(t + dt)−} −






{Zi(t) − Z(t; θ)}dNTi (t),
40




T (t; θ), R
(p)
T (t; θ) = n
−1 ∑n
i=1 Yi(t)Zi(t)
⊗p exp{θ′Zi(t)}, p =
0, 1, 2, where, for a vector z, z⊗0 = 1, z⊗1 = z, z⊗2 = zz′. The Breslow estimator of
ΛT0 (t) is given by Λ̂
T









After estimating the treatment hazards, we come back to the death hazard mod-









Aik{Zi0k − Z0k(t; β, W )}W Aik(t)dNi0k(t),




0k (t; β0) and R
(d)







with d = 0, 1, 2 and where τ0k satisfies P{Yi0k(τ0k) = 1} > 0, and can in practice be
set to the largest observation time start from the kth cross section. As defined in
Chapter II, an appropriate IPCW weight is given by W Aik(t) = Yi0k(t) exp{ΛTi (Sik +





0 (u; θ0) exp{θ′0Zi(u)}du,
However, in practice, some values of W Aik(t) could be very large and result in
increased variance of β̂0. In order to improve the precision of β̂0, a stabilized weight
is suggested,
W Bik (t) = Yi0k(t)
exp{ΛTi (Sik + t) − ΛTi (Sik)}
exp{ΛTik(t)}
,
analogous to procedures suggested by Robins and Finkelstein (2000) and Miloslavsky
et al. (2004), where ΛTik(t) is the cumulative hazard from a proportional hazards
model which takes transplant as the event and adjusts only for covariates up to the
cross-section time, λTik(t) = λ
T
0k(t) exp{θ′1Zi0k} and t is the time from entry to study
with θ1 as covariate effect.
With stratum-specific baseline hazards estimated, a weighted version of the Breslow-
Aalen estimator pooled across strata could be obtained,


















After estimating all the necessary parameters, for previous follow-up time Si, we




Compared to treatment-free survival, the estimation of the post-treatment pa-
rameters is more conventional. The following model is assumed,
λi1(t; Ti) = λ01(t) exp{β ′Zi(Ti)},
and fitted using observed post-transplant data. Note t here is from treatment initi-
ation forward. Correspondingly, we define the counting process Ni1(t) = Ni(Ti + t)
with increment dNi1(t) = Ni1{(t + dt)−} − Ni1(t) and at risk indicator Yi1(t) =
Yi(Ti + t). Define Zi1 = Zi(Ti). Ni1(t) and Yi1(t) are defined to be 0 if patient i
never receives treatments; i.e., NTi (Xi) = 0. Since Ti is only subject to independent
censoring, standard partial likelihood method can be applied to estimate β1, that is,






{Zi1 − Z1(t; β)}dNi1(t),





i1 exp{β ′1Zi1}, for p = 0, 1, 2. The Breslow estimator has the form













As a result, the subject specific treatment effect can be expressed as
Δi(Si) = μi1(Si) − μi0(Si),
which can be estimated by replacing all parameters with their corresponding afore-
listed estimators. The subject specific difference in survival probability at time t is
defined as
SΔi(t; Si) = Si1(t; Si) − Si0(t; Si).
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Our main objective is to evaluate the average treatment effect under the current
treatment assignment patterns. As implied previously, patients are selected for treat-
ment non-randomly. We wish to estimate the average difference in restricted mean
survival time, given the true (i.e., uncensored) distribution of {Ti, Zi(Ti)}. This
involves taking a weighted average of Δi(Ti) estimators for subjects who received
treatment {Ti, Zi(Ti) : Ti < Xi}. A simple unweighted average will make the average
treatment effect a function of censoring distribution, which is not desirable. Similar
to a Horvitz and Thompson (1952) estimator, we weight each observed transplant
by the inverse of the probability of remaining uncensored. The weighted data repre-
sent what would have been observed in the absence of independent censoring by Ci.
The average treatment effect is is defined as Δ = E[Δ(T )] where the expectation
sign is with respect to the joint distribution of {Ti, Zi(Ti), Ti < τ, Ti < D0i }, with













where Gi(t) = P{Ci > t|Zi(0)}. We estimate Gi(t) via a standard Cox model,
λCi (t) = λ
C
0 (t) exp{α′0Zi(0)},
fitted to {Xi, I(Ci < Di), Zi(0)}, where t represents follow-up time. The quantity Δ
represents the average number of time units (e.g., years) saved by treatment (out of
the next L years).
Analogously, the average difference in survival probability at time t is defined as















We assume that the random vectors {Xi, Ni(·), NTi (·), Z̃i(Xi)}, for i = 1 . . . n, are
independent and identically distributed, with Zi(t) bounded for t ∈ (0, τ ], where τ
satisfies P (Xi ≥ τ) > 0. We summarize the asymptotic properties of the proposed
methods in Theorem III.1 with all regularity conditions listed in Appendix B.
Theorem III.1. Under certain regularity conditions, n1/2[ŜΔ(t)−SΔ(t)] and n1/2(Δ̂−
Δ) converge asymptotically to a zero-mean Gaussian processes with covariance func-
tions E[ξj(t)
2] and E[η2j ], respectively, where {ξ1(t), . . . , ξn(t)} and {η1, . . . , ηn} are
i.i.d. with mean 0 asymptotically, and
ξj(t) = V (τ)
−1
{
V1j(t) + V2j(t) +
∫ τ
0




































−1UCj (α0) + J
C
ij (t)},
ϕSij(t) = Si0(t){Λi0(t)Zi(Si)′Ω−10 (β0)Uj0(β0) − eβ
′
0Zi(t)Φj0(t)},
−Si1(t){Λi1(t)Z ′i1Ω−11 (β1)Uj1(β1) − eβ
′
1Zi1Φj1(t)},





j (α0) and J
C
ij (t) defined in Appendix B.
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2, where η̂i and ξ̂i(t) are estimated by changing all limiting values in
ϕi by their empirical counterparts. A proof of Theorem III.1 is given in Appendix
B. The main idea of the proof is demonstrating that, asymptotically, n1/2(Δ̂−Δ) =
n−1/2
∑n
i=1 ηi + op(1) and n
1/2{ŜΔ(t) − SΔ(t)} = n−1/2
∑n
i=1 ξi(t) + op(1) through a
sequence of Taylor series expansions.
The proof is provided for the weight, W Aik(t) = Yi0k(t) exp{ΛTi (Sik + t)−ΛTi (Sik)}.
In practice, a stabilized weight is preferred to improve precision. As shown by The-
orem III.1, the computation of the variance is already very complicated, and is more
complicated when a stabilizer is incorporated. Such concerns motivate a computa-
tionally simpler form for the variance estimator. That is, to take the weight W Aik(t),
or W Bik (t) and Gi(t)
−1, as the case may be as fixed. Then, the variance estimator of


































ϕS∗ij (t) = Si0(t){Λi0(t)Zi(Si)′Ω−10 (β0)Uj0(β0) − eβ
′
0Zi(t)Φ∗j0(t)}


































dMi0k(t) = dNi0k(t) − Yi0k(t)dΛi0(t),
dMi1(t) = dNi1(t) − Yi1(t)dΛi1(t),
where z0(t; β, W ), r
(0)
0 (t; β0, W ), z1(t; β1) and r
(0)
1 (t; β1) are the infinity values of
Z0(t; β, W ), R
(0)
0 (t; β0, W ), Z1(t; β1) and R
(0)
1 (t; β1), respectively.
3.4 Simulation
For treatment-free survival, we modify the settings in Zheng and Heagerty (2005)
to generate data following the assumed partly conditional model. First, we generate
a single binary treatment group indicator Zia, with value 0 and 1 with probability
0.5. A single longitudinal covariate Zi(Sik) measured at a common set of cross section
dates CS1, CS2, . . . , CSK is then created. To generate data {Di, Zia, Zib} where Zib =
vec{Zi(Sik)}, we first let Zib0 = bi +
∑K
k=1 log(Vik)/γ2, where bi ∼ N(μ, σ2) and Vik ∼
P (ρ), independent positive stable random variables with index ρ (Samoridnitsky and
Taqqu, 1994). A pre-treatment death time Di, is then generated with a hazard
λi(t) = V
1/ρ
i0 λ0(t) exp{γ1Zia + γ2Zib0}, where Vi0 ∼ P (ρ) and is independent of Vik,
with Λ0(t) = (t/a)
1/ρ2 and a is a constant. Let Zi(Sik) = Zib0 − log(Vik)/γ2. Then,
the death hazard can be written as
λi(t) = V
1/ρ
i0 λ0(t) exp{γ1Zia + γ2Zi(Sik) + log(Vik)}.(3.3)
The ith subject enters the study on calendar date, Li, which is generated from a
Uniform(0, b) distribution. Treatment time, Ti, is generated from the proportional
hazards model,
λTi (t) = λ
T
0 (t) exp{θ01Zia + θ02I(t > Ri)},(3.4)
where λT0 (t) = d3 and θ0 = (θ01, θ02) and the time of treatment-ineligibility, Ri, is
generated with hazard λRi (t) = λ
R
0 (t) exp{d1Vi0}, where λR0 (t) = d2. Thus, Ri and
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Di are positively correlated, which is consistent with the data which motivated the
proposed methods. Administrative censoring time, Ci, is generated from hazard
λCi (t) = λ
C
0 (t) exp{α0Zia},(3.5)
where λC0 (t) = d4. Note that treatment time and pre-treatment death time, Ti, and
Di are dependent since both depend on treatment-ineligibility time Ri. However,
independent censoring time Ci is independent with Di conditional on Zia.
To see how the preceding set-ups generate proportional hazards in the partly
conditional setting, integrate both sides of the expression (3.3),
Λi(t) = V
1/ρ
i0 Λ0(t) exp{γ1Zia + γ2Zi(Sik)}Vik,
such that the pre-treatment survival function is given by
exp[−Λi(t)] = exp[−Λ0(t) exp{γ1Zia + γ2Zi(Sik)}VikV 1/ρi0 ].
Now, transforming the time scale to reflect time since cross section, define tk = t−Sik.
Then, take the expectation with respect to Vik first and from the property of positive
stable distribution, we have
exp[−Λi(tk|Zia, Zi(Sik), Di > Sik, Vi0)] = exp[−(Λ0(t) exp{γ1Zia+γ2Zi(Sik)}V 1/ρi0 )ρ/ cos(πρ/2)].
Then, taking the expectation with respect to Vi0, we have
exp[−Λi(tk|Zia, Zi(Sik), Di > Sik)] = exp[−(Λ0(t)ρ2 exp{ρ2γ1Zia+ρ2γ2Zi(Sik)}/ cos(πρ/2)(ρ+1)],
which implies the following equation after taking the logarithm and negating both
sides,
Λi(tk|Zia, Zi(Sik), Di > Sik) = Λ0(t)ρ2 exp{ρ2γ1Zia + ρ2γ2Zi(Sik)}/ cos(πρ/2)(ρ+1).
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Transforming the time scale, we then obtain,




Using this construction, the hazard for Dik = Di − Sik will generally depend on Sik
and, therefore, stratified models similar to those considered by Wei, Lin, and Weiss-
feld (1989) would be appropriate. With Λ0(t) = (t/a)
1/ρ2 and λ0(tk +Sik)ρ
2{Λ0(tk +
Sik)}(ρ2−1) = 1/a, it follows that
λi(tk|Zia, Zi(Sik), Di > Sik) = exp{ρ2γ1Zia + ρ2γ2Zi(Sik)}/[a cos(πρ/2)(ρ+1)].
If we define λi0k(t; Sik) = λi(tk|Zia, Zi(Sik), Di > Sik), λ00k(t) = [a cos(πρ/2)(ρ+1)]−1
and β0 = (β01, β02) = (ρ
2γ1, ρ
2γ2), then the proportional hazards model for pre-
treatment death time is given by
λi0k(t; Sik) = λ00k(t) exp{β01Zia + β02Zi(Sik)}.(3.6)
We only include for analysis those Zi(Sik) with Li < Sik < min(Xi, Ri).
For patients who received treatment prior to dying (Di > Ti), a post-treatment
death time D1i − Ti, is then generated via hazard
λi1(t; Ti) = λ01(t) exp{β11Zia + β12Zi(Ti)},(3.7)
where t represents time from treatment date Ti forward and β1 = (β11, β12) =
(ρ2γ1, ρ
2γ2). We set λ01(t) = a1.
After generating the data, the pre-treatment death data since cross section,
{Xik, Nik(·), Zia, Zi(Sik)} are used to fit model (3.6); treatment data {Xi, NTi (Xi), Zia, Zi(t)}
are used to fit model (3.4); censoring data {Xi, NCi (·), Zia, Zi(0)} are used to fit model
(3.5); post-treatment death data {Xi − Ti, Zia, Zi(Ti); NTi (Xi) = 1} are used in the
fitting of (3.7).
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We evaluate samples with n = 500 subjects and obtain censoring and transplant
rates as approximately [10%, 10%], [15%, 15%] and [20%, 20%] with a = 2000, 5000, 7000
respectively. There are K = 10 cross section dates. We set b = 500, (θ01, θ02) =
(−1,−1), μ = 18, σ = 1, (γ1, γ2) = (−1,−0.5) and d1 = d2 = d3 = d4 = 0.001. We
set CSk = 100 × k. For all our simulated data configurations, 1000 Monte Carlo
data sets are used. We present results using ρ = 0.8, thus (β01, β02) = (β11, β12) =
(−0.64,−0.32). With the number of cross sections set to K = 10, the average num-
ber of records per subject is 0.7 to 2.4, depending on the censoring level. Since we
consider a 3-year restricted mean survival time and try to simulate time data in
“day” scale, we set L = 365 × 3 = 1095. Two scenarios are given, positive effect of
treatment on mean survival (Δ > 0) with a1 = 0.5 × 10−4, and no treatment effect
(Δ = 0) with a1 = [a cos(πρ/2)
(ρ+1)]−1 .
We applied the simplified variance estimator in which {Ŵ Aik(t)}, {Ŵ Bik (t)} and
{Ĝi(t)−1} are all treated as fixed; i.e., in (3.2) and (3.1). Table 3.1 presents the
simulation results for the case with Δ = 0, while Table 3.2 provides results for Δ > 0
cases. The quantity Δ equals the difference of 3-year restricted mean survival time
post- versus pre-treatment. The proposed estimators appear to be approximately
unbiased and coverage probabilities of Δ are close to the nominal 95% level.
3.5 Application
We applied the proposed methods to estimate the average effect of liver trans-
plantation among the transplanted, by Model for End-stage Liver Disease (MELD)
score. Data were obtained from the Scientific Registry of Transplant Recipients
(SRTR), a national population based organ transplant registry. The study popula-
tion consists of patients initially wait listed for deceased-donor liver transplantation
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Table 3.1: Simulation result for Δ = 0 with {W Bik (t)}.
n=500 Δ = 0
[Censor,Treat] True Value Term(yr) Bias ESE ASE CP
[10%, 10%] 0 Δ 0.040 0.204 0.190 0.92
0 SΔ(1) 0.012 0.089 0.082 0.92
0 SΔ(2) 0.016 0.092 0.085 0.93
0 SΔ(3) 0.022 0.094 0.082 0.91
[15%, 15%] 0 Δ 0.022 0.164 0.154 0.93
0 SΔ(1) 0.007 0.065 0.061 0.93
0 SΔ(2) 0.010 0.077 0.072 0.93
0 SΔ(3) 0.010 0.083 0.077 0.91
[20%, 20%] 0 Δ 0.009 0.144 0.141 0.94
0 SΔ(1) 0.001 0.056 0.054 0.93
0 SΔ(2) 0.004 0.067 0.066 0.94
0 SΔ(3) 0.005 0.074 0.073 0.94
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Table 3.2: Simulation result for Δ > 0 with {W Bik (t)}.
n=500 Δ > 0
[Censor,Treat] True Value Term(yr) Bias ESE ASE CP
[10%, 10%] 0.871 Δ 0.030 0.204 0.190 0.92
0.294 SΔ(1) 0.009 0.088 0.074 0.92
0.346 SΔ(2) 0.009 0.100 0.088 0.92
0.350 SΔ(3) 0.008 0.110 0.097 0.92
[15%, 15%] 0.614 Δ 0.017 0.150 0.145 0.94
0.193 SΔ(1) 0.006 0.054 0.052 0.94
0.253 SΔ(2) 0.008 0.070 0.068 0.94
0.278 SΔ(3) 0.005 0.082 0.077 0.92
[20%, 20%] 0.427 Δ 0.020 0.135 0.133 0.94
0.133 SΔ(1) 0.006 0.048 0.048 0.94
0.177 SΔ(2) 0.009 0.064 0.062 0.93
0.197 SΔ(3) 0.006 0.077 0.072 0.93
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between March 1, 2002 and December 31, 2009 in the United States. Only adult
patients (age ≥ 18 at listing) not previously transplanted (i.e., not repeat transplant
candidates) were included in the study cohort. Patients who were Status 1 at t = 0
were excluded. Cross-section dates were chosen every 7 days, 30 days or 90 days
from 03/01/2002 to 12/31/2009, which lead to K = 409, 96, 32 cross sections respec-
tively. Three different cross-section frequencies dates were chosen in order to study
the behavior of the proposed methods.
In order to construct the IPCW weight, ΛTi (t) was estimated through a time-
dependent Cox model in which transplant was the event. For the time-to-transplant
model, time t starts from the beginning of the follow-up (the date of wait listing), as




where the subscript r = 1, . . . , 11 stands for United Network for Organ Sharing
(UNOS) region. The presence of the indicator, Ai(t), reflects the fact that a patient’s
time while inactive or removed does not contribute to the estimation of θ0 or Λ
T
0r(t).
The covariate, Zi(t), included MELD score, Status 1, albumin, age, gender, race,
diagnosis of Hepatitis C, body mass index, diabetes, hospitalization, blood type,
dialysis within prior week, encephalopathy, ascites and serum creatinine.
To obtain the weight Gi(t)
−1, ΛCi (t) was estimated through a baseline Cox model
in which administrative censoring was the event. As in the time-to-transplant model,
time t starts from the beginning of the follow-up. Covariates evaluated at baseline,
Zi(0), included MELD score, albumin, age, gender, race, diagnosis, body mass index,
diabetes, hospitalization status at listing and previous malignancy.
For the weight, some very large values occurred. Since we found that 99% of
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W Bikr(t) and Gi(t)
−1 were less than 10, both weights were then capped at 10. The
time-to-transplant and time-to-censoring models are regressed on the entire study
cohort (i.e., one single model). Separate pre-transplant death models were fitted
for each of the following MELD score categories: 6-8, 9-11, 12-14, 15-17, 18-19, 20-
22, 23-25, 26-29, 30-35 and 36-40. One single post-transplant model was fitted to
all MELD score categories. Then the proposed death models were applied to the
chosen cohort. The pre-transplant data were divided into subgroups by MELD due
to computational burden.
The pre-transplant death model, was also stratified
λi0kr(t) = λ00kr(t) exp{β ′0Zik},
where the subscript r = 1, . . . , 11 again stands for UNOS region and k = 1, . . . , K
stands for cross section. The subject level covariates at cross section k, Zik, included
MELD score, albumin, age, gender, race, diagnosis, body mass index, diabetes, hos-
pitalization status at listing, previous dialysis and malignancy. Also included in
Zik were time on wait-list, average change in MELD score (pertaining to the time
interval between the date of listing and cross-section k date, and estimated using or-
dinary least squares) and average change in albumin (estimated analogously). Other
elements included the percentage of time spent in inactive status, and percent of
time receiving dialysis. Since 99% of MELD and albumin slope values before cross
sections fell in the [-1,1] interval, the slopes were bounded by -1 and 1.
The post-transplant death model is expressed as
λi1(t) = λ01(t) exp{β ′1Zi(Ti)}.
The subject level covariates at transplant time Ti, Zi(Ti), included MELD score,
albumin, age, gender, race, diagnosis, body mass index, diabetes, hospitalization
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status at listing, previous dialysis and malignancy, donor risk index (DRI; Feng
et al., 2006) and time on wait-list.
The sample in pre-transplant period consisted of n = 66, 884 patients, of which
36,260 were observed to receive a deceased-donor liver transplant. Estimates of
the difference in restricted mean survival time, Δ, based on the death model using
the Type B weight are listed in Table 3.3. Estimates of the difference in survival
probability, SΔ(t) are shown in Table 3.4 for t = 1, 3, 5 years. For the MELD 30-40
subgroup, weekly cross section dates were chosen. For MELD 18-29 cross sections
were drawn monthly. For MELD 6-17, cross sections were drawn every 3 months.
Note that, we also tried weekly cross section dates for MELD 6-29 patients, which
yielded almost identical results. There was an obvious monotone pattern in that,
as MELD and restricted time L went up, estimates of differences in both restricted
mean lifetime and survival probability increased.
Figure 3.2 shows the estimated average pre- and post-transplant survival curves
for MELD group 6-8, 15-17, 20-22 and 36-40. For MELD 36-40 group, the wait list
survival curve drops dramatically during the first couple of months, then steadily
declines thereafter. As MELD score decreases, the difference between the two survival
curves generally diminishes and the dropping slope of the wait list curve becomes
closer to a constant; a phenomenon is quite obvious in the plot of the MELD 6-8
group.
3.6 Discussion
In this chapter, we proposed pre- and post-treatment models for estimating the
average effect of a time-dependent treatment via differences in survival probability
and restricted mean lifetime. A proportional hazards model which uses covariate
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Table 3.3: Estimate of Δ(SE) by MELD groups.
MELD 1 Year 3 Years 5 Years
36-40 0.47 1.43 2.38
(0.04) (0.18) (0.34)
30-35 0.30 0.88 1.40
(0.04) (0.34) (0.75)
26-29 0.20 0.63 0.99
(0.03) (0.11) (0.20)
23-25 0.12 0.57 1.07
(0.01) (0.07) (0.14)
20-22 0.10 0.62 1.23
(0.02) (0.07) (0.14)
18-19 0.07 0.51 1.06
(0.01) (0.04) (0.08)
15-17 0.03 0.40 1.00
(0.01) (0.05) (0.10)
12-14 -0.01 0.18 0.59
(0.01) (0.04) (0.08)
9-11 -0.03 0.03 0.29
(0.01) (0.03) (0.07)
6-8 -0.04 -0.04 0.11
(0.01) (0.03) (0.07)
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Table 3.4: Estimate of SΔ(SE) by MELD groups.
MELD 1 Year 3 Years 5 Years
36-40 0.48 0.48 0.45
(0.04) (0.06) (0.06)
30-35 0.33 0.27 0.25
(0.04) (0.10) (0.12)
26-29 0.25 0.19 0.16
(0.04) (0.04) (0.05)
23-25 0.19 0.23 0.26
(0.02) (0.02) (0.04)
20-22 0.19 0.29 0.30
(0.02) (0.03) (0.03)
18-19 0.15 0.26 0.27
(0.01) (0.01) (0.02)
15-17 0.09 0.26 0.32
(0.01) (0.02) (0.02)
12-14 0.02 0.16 0.23
(0.01) (0.02) (0.02)
9-11 -0.02 0.09 0.17
(0.01) (0.01) (0.01)
6-8 -0.03 0.03 0.11
(0.01) (0.01) (0.02)
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Figure 3.2: Estimated post- and pre-transplant survival curves by MELD score at
transplant.
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history up to the treatment time is assumed for the post-treatment death hazard. A
cross-section-based partly conditional survival model which conditions on covariate
history up to and time since the cross-section times is used for the treatment-free
death hazard. This cross-section-based model to allows the estimation of treatment-
free survival for treated patients. Thus the comparison in survival probability or
restricted mean lifetime with versus without treatment at the same time point, the
treatment time, is made possible. In the partly conditional survival model, values
of covariates are fixed at cross-section time and multiple cross-sections are drawn
with data of each serves as a stratum. Freezing the covariate value could be seem as
a marginal way of estimation, which averages over all the possible future covariate
paths. However, since only part of the covariate history is conditioned on, receiving
treatment results in the dependent censoring of death. A revised version of IPCW
is applied in aiming to estimate the effect consistently in the presence of dependent
censoring. With pre- and post-treatment survival curves estimated, treatment effect
could be obtained at the subject level based on each patient’s covariate values at
treatment time. To construct the average treatment benefit, another IPCW weighted
average of subject level estimates is used to weight out the effect of administrative
censoring.
CHAPTER IV
Semiparametric Cumulative Contrasts of
Group-Specific Mortality in the Presence of
Dependent Censoring
4.1 Introduction
In medical and clinical studies, nonproportional hazards and dependent censoring
are two common issues. For example, in comparing mortality across different groups
of patients, discrepancies in mortality by group may not be constant over follow-up
time. In the context of the Cox (1972) model, nonproportionality could be handled
by assuming that the group-specific hazard ratio effect changes with a specific pat-
tern that can be represented parametrically. For example, the effect could be piece
wise constant, or follow a continuous function. However, usually it is generally quite
challenging to confirm the correctness of the selected parametric form. Moreover,
when the effect is time-varying, investigators tend to be more interested in the cu-
mulative effect; i.e. if and when the treatment-specific survival (or, equivalently the
cumulative hazard) functions cross.
Another frequently arising issue is dependent censoring, which can occur when
both the death and censoring process depend on overlapping time-varying covariates
not captured in the death hazard model. Effect estimators that rely on censoring
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and death being independent are generally no longer consistent in the presence of
dependent censoring. If adjustment is made for the covariates that vary over time,
the effect estimates then represent differences between subjects with equal covariate
paths over time, which is usually of secondary interest at most.
Wei and Schaubel (2008) proposed estimating the cumulative treatment effect
using a stratified Cox model with treatment groups as strata. The methods require
no assumptions on the pattern of the group effect on mortality over time, although
proportionality is assumed to hold within-group for the adjustment convariates. The
ratio of stratum-specific cumulative baseline hazards is used to estimate the cumu-
lative treatment effect over time.
The method of Wei and Schaubel (2008) assumes that censoring is conditionally
independent of death given treatment and the adjustment covariates. This assump-
tion frequently fails in practice, particularly for observational studies. Robins and
Rotnitzky (1992), Robins and Finkelstein (2000) proposed Inverse Probability of
Censoring Weighting (IPCW) to obtain consistent estimators in the presence of de-
pendent censoring.
The motivation for the proposed methods arises from wait-list mortality com-
parisons among End-Stage Liver Disease (ESLD) patients. The preferred treatment
for ESLD is deceased-donor liver transplantation. However, the number of available
organs is always less than the number of patients on the liver transplant waiting list.
According to the current liver allocation guidelines, the sickest patients are priori-
tized to the top of the waiting list, where Status-1 patients are in front of the queue,
followed by chronic patients in decreasing order of Model for End-Stage Liver Disease
(MELD) score. Note that MELD scores are updated over time and, thus, MELD is a
time-varying covariate. MELD scores are highly predictive of both wait list mortality
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and liver transplant rates; the latter being due to the liver allocation policy which
has been in place since 2002. Therefore, liver transplantation represents dependent
censoring for wait-list death unless adjustment is made for the time-dependent pre-
dictors, such as MELD score. However, adjusting for time-dependent covariates will
bias the group effect estimate towards the null. As a result, the receipt of a liver
transplant results in the dependent censoring of wait list death time, in the presence
of adjustment for baseline (time 0) covariates only. Preliminary analysis has revealed
that the Kaplan-Meier curves for high-MELD patients later cross that for Status-1
patients, which implies that the among-group proportionality assumption fails. An-
other issue is that due to health conditions, patients can be permanently removed
from or temporarily inactive on the wait-list, during which time intervals they are
not eligible to receive an organ transplant.
When proportionality fails, some authors estimated the causal inference, or av-
erage hazard ratio, using marginal structural models (e.g., Hernan, Brumback, and
Robins, 2000, 2001; Robins, Hernan, and Brumback, 2000). Various authors esti-
mated restricted mean survival time (Chen and Tsiatis, 2001; Zhang and Schaubel,
2010). However, contrasts between restricted mean lifetime do not describe how the
effect on survival changes over time. Wei and Schaubel (2008) proposed a ratio of
the cumulative hazards to quantify the group effect without considering dependent
censoring. Schaubel and Wei (2011) later proposed the ratio of cumulative hazard
over time and used IPCW to overcome the dependent censoring. However, Inverse
Probability of Treatment Weighting (IPTW) was used instead of covariate adjust-
ment in the death model, which estimates a quantity analogous to the average causal
effect, which may not be of chief interest in certain applications. In summary, due
to interest in the shape of the time-varying effect, the presence of dependent cen-
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soring and the potential for subjects to become treatment ineligible, none of the
afore-mentioned methods can be applied to our ESLD motivating example directly.
In this chapter, we propose the ratio of IPCW-weighted baseline cumulative haz-
ards as an estimator of the group effect on mortality over time. Essentially, the
proposed method extends that of Wei and Schaubel (2008) to the dependent censor-
ing setting. Since only baseline, opposed to time-dependent covariates, are adjusted
for, dependent censoring occurs and is overcome by IPCW, with a stabilized ver-
sion of weight applied to increase precision. To construct the IPCW weight, a time-
dependent Cox model with treatment as the event is adopted. The time-to-treatment
model is conditional on being treatment-eligible, such that treatment-ineligible time
intervals do not contribute to the treatment hazards; reflective of the fact that organs
are not allocated to removed or inactive patients in the motivating example.
The remainder of this chapter is organized as follows. In Section 4.2, we provide
the notation and describe the proposed estimator. How consistent estimation is
obtained in presence of dependent censoring through IPCW method is also explained.
Asymptotic properties of the proposed estimator are given in Section 4.3. Simulation
studies are provided in Section 4.4 to evaluate the performance of the proposed
methods in finite samples. The proposed methods are applied to liver wait list
mortality using data from a national registry in Section 4.5. In Section 4.6, we
provide some concluding remarks and discussion. Asymptotic derivations are given
in Appendix C.
4.2 Proposed Methods
First, we set up the necessary notation. Let Di be the time to failure for subject i,
with i = 1, . . . , n. We assume that Di may be right censored at treatment time, Ti, or
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independent censoring time, Ci, and therefore we only observe Xi = min(Di, Ti, Ci)
and associated indicators Δi = I(Xi = Di) and Δ
T
i = I(Xi = Ti), where I(A) = 1
is event A is true, and 0 otherwise. Let J be the number of groups with index
j = 0, 1, 2, . . . , J − 1. The first group (j = 0) serves as the reference category, to
which all other groups are compared. Define the death counting process, Ni(t) =
Ii(Xi ≤ t, Δi = 1) with associated increment dNi(t) = Ni{(t + dt)−} − Ni(t) and
at-risk process, Yi(t) = I(Xi ≥ t). Let Gi be the group variable for ith subject
and define Gij = I(Gi = j). Similarly, we have Yij(t) = Yi(t)Gij and dNij(t) =
dNi(t)Gij as the at risk and counting process for ith subject and jth group. Note
that group is defined at t = 0. With respect to the treatment process, define NTi (t) =
Ii(Xi ≤ t, ΔTi = 1) with increment dNTi (t) = NTi {(t + dt)−} − NTi (t). Let Ai(t) be
1 if patient i is eligible to receive treatment as of time t, and 0 otherwise, and set
Ãi(t) = {Ai(s); s ∈ [0, t)}. Note that, since treatment-initiation never occurs when a
patient is treatment-ineligible, dNTi (t) = Ai(t)dN
T
i (t). Thus n independent vectors
are observed from subjects, {Xi, Δi, ΔTi , Gi, Z̃i(Xi), Ãi(Xi)}, where Zi(t) is the time-
varying covariate and Z̃i(t) = {Zi(s); s ∈ [0, t)} is the covariate history on [0, t). Set
Zi0 ≡ Zi(0) as the baseline covariates.
A variant of Inverse Probability of Censoring Weighting (IPCW) is used to over-
come the dependent censoring of Di via Ti. First, we assume that the treatment
time Ti follows the Cox model,
λTi (t) = Ai(t)λ
T
0 (t) exp{θ′0Zi(t)},
where the inclusion of Ai(t) reflects the fact that the treatment hazard is zero at
times during which the subject is treatment-ineligible. The IPCW weight is given





i (s)ds. The Breslow-type
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T (s, θ) with Λ̂
T
i (t, θ) =∫ t
0




d = 0, 1, 2. z⊗0 = 1, z⊗1 = z and z⊗2 = zz′, if z is a vector. The coefficient θ0 is






{Zi(t) − Z(t; θ)}dNTi (t),




T (t; θ), and the constant τ satisfies P (Xi ≥ τ) > 0.
We assume that death time Di follows a stratified proportional hazards model,
with hazard function
λij(t) ≡ λ(t|Gi = j, Zi0) = λ0j(t) exp{β ′0Zi0},
where Zi0 = Zi(0) and λ0j(t) is the unspecified baseline hazard function for group
j. Proportional hazards are not assumed across groups, but are assumed for the
adjustment covariate, Zi0.
The regression parameter for the adjustment covariate, β0, can be estimated as
the root of the stratified inverse-weighted score function,







{Zi0 − Zj(t; β, W )}Wi(t)dNij(t),
where Zj(t; β, W ) = R
(1)
j (t; β, W )/R
(0)
j (t; β, W ), R
(d)





exp(β ′Zi0) for d = 0, 1, 2. With some algebra, dNij(t) in (4.1) can be replaced by
dMij(t) = dNij(t) − Yij(t)dΛij(t), such that the score function can be written as







{Zi0 − Zj(t; β, W )}Wi(t)dMij(t).
A consistent estimator of β0 should satisfy E[Wi(t)dMij(t)|Zi0] = 0. We can write




ij(t) = I(Di ≥ t)[dN∗ij(t) − dΛij(t)]
and N∗ij(t) = I(Di ≤ t)Gij . Under the assumed model, E[dM∗ij(t) |Zi0, Gi] = 0,
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which leads to E[I(Ti > t)dM
∗
ij(t)|Zi0, Gi] = 0 in the case of independent cen-
soring. In the presence of dependent censoring, without the IPCW term Wi(t),
E[dMij(t)|Zi0, Gi] = 0 since E[dMij(t)|Zi0, Gi] = E[I(Ti > t)I(Ci > t)|Zi0, Gi]
E[dM∗ij(t)|Zi0, Gi]. However, it can be shown that E[Wi(t)dMij(t)|Zi0, Zi(t), Gi] = 0
and, after iterating the expectation, we have E[Wi(t)dMij(t)|Zi0, Gi] = 0, such that
the weighted score function, (4.1), is unbiased. The weighted Breslow estimator is
then computed as









j (t; β, W )
,
and is a consistent estimator of Λ0j(t) in the presence of dependent censoring.
However, in practice, some values of Wi(t) can be very large due to Λ̂
T
i (t) being
unduly large, which can result in β̂ and Λ̂0j(t) being quite imprecise. In order to
improve the precision of the estimate, similar to Robins and Finkelstein (2000) and
Miloslavsky et al. (2004), a stabilized weight is define as




where ΛTi (t|Zi0, Gi) is the cumulative hazard from a treatment hazards model which
accounts for baseline covariate values only, λTi (t|Zi0, Gi) = λT0 (t|Zi0, Gi) exp{θ′1Zi0}
with θ1 the effect coefficient. We refer to Wi(t) as “unstabilized” hereafter.
To compare each group to the reference group, the following measure is proposed,
φj(t) =
Λij(t|Zi0 = z)




for j = 0, 1, . . . , J − 1. The measure φj(t) contrasts patients with same covariate pat-
tern but in different groups. Note that if proportionality holds for groups, then φj(t)
reduces to a time invariant constant, which is commonly referred to as the hazard
ratio. After obtaining the cumulative baseline hazard estimators and substituting
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, t ∈ [tL, tU ],
where tL is chosen to be large enough to avoid Λ̂00(t, β̂) = 0 and tU is chosen to avoid
instability estimate at the tail of the observation time distribution.
4.3 Asymptotic Properties
Regularity conditions are listed explicitly in Appendix C. In particular, we assume
that the random vectors {Xi, Δi, ΔTi , Z̃i(Xi), Ãi(Xi)}, for i = 1 . . . n, are independent
and identically distributed, with Zi(t) bounded for t ∈ (0, τ ], where τ satisfies P (Xi ≥
τ) > 0. The asymptotic properties of the proposed methods are summarized in the
following theorem.
Theorem IV.1. Under certain regularity conditions, n1/2{φ̂j(t) − φj(t)} converges
asymptotically to a zero-mean Gaussian process with covariance function σj(s, t) =




























hj(t; β, W ) = −
∫ t
0
z′j(u; β, W )dΛ0j(u),
r
(0)
j (t; β, W ) = Ei[Wi(t)Yij(t) exp{β ′Zi0}],
r
(0)
T (t; θ) = Ei[Yi(t) exp{θ′Zi(t)}],
dMTi (t) = dN
T
i (t) − Yi(t)dΛTi (t),
66
with Ω(β), Ui(β), Bj(t), Ej(t), ΩT (θ), U
T
i (θ), Kj(t1, t2) and Pj(t1, t2) defined in
Appendix C.
The covariance can be estimated consistently by σ̂j(s, t) = n
−1 ∑n
i=1 ξ̂ij(s)ξ̂ij(t),
where ξ̂i(t) is obtained by replacing all limiting values in ϕi by their empirical coun-
terparts. A proof of Theorem III.1 is given in Appendix C. The proof basically
shows that, asymptotically, n1/2{φ̂j(t)− φj(t)} = n−1/2
∑n
i=1 ξ̂ij(t) + op(1) through a
sequence of Taylor series expansions.
The proof is for the unstabilized weight, Wi(t) while a stabilized version W
S
i (t)
is preferred. As implied by Theorem III.1, the computation of the variance is
quite complicated, and is obviously more complicated with the stabilizer. A com-
putationally simpler variance treats the weight Wik(t), or W
S
ik(t), as fixed in the























j (u; β0, W )
−1Wi(u)dMij(u).
This is the variance estimator that we suggest and evaluate through simulations
described in the next section.
4.4 Simulation
We modify the setups of Zhang and Schaubel (2010) to generate data for the sim-
ulation study. First, a single baseline covariate Zi is created as a truncated standard
normal variable, truncated at -4 and 4. The group indicator Gi is then generated
from a Bernoulli distribution with parameter exp(−0.6Zi)/{1+exp(−0.6Zi)}. Death
time Di is generated by transforming ε1i ∼ Uniform(0, 1) using the inverse of the
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cumulative distribution function of a Weibull distribution with hazard function
λij(t) = αjγjt
γj−1 exp{β ′0Zi},(4.3)
for subject i = 1, . . . , n and group j = 0, 1. Unless γ0 = γ1, proportionality does not
hold across groups. Different values of γj’s are chosen to lead to a constant, increasing
or decreasing true cumulative hazard ratio function φj(t). After that, we generate a
time-dependent covariate which correlates with both death time Di and treatment
time Ti conditional on (Gi, Zi). First let Vti = −2 log{Giε1i +(1−Gi)(1− ε1i)}+ ε2i,
where ε2i ∼ Uniform(0, 1). Define Vi(t) = I(Vti ≥ t). Thus Vi(t) is correlated
with event time Di when conditional on (Gi, Zi). Then, Ti is generated to follow the
proportional hazards model,
λTi (t) = λ
T
0 (t) exp{θ0 + θGGi + θZZi + θ1Vi(t)},(4.4)
such that Vi(t) correlates with Ti. Consequently Di is dependently censored by Ti,
even conditional on (Gi, Zi). To simplify the setup, administrative censoring time Ci
is not involved in the simulation study. Data pertaining to death time {Xi, Δi, Zi}
is used to fit model (4.3), with time to transplant data {Xi, ΔTi , Zi, Vi(Xi)} used to
fit model (4.4).
We evaluate samples of size n = 500, 250, 100 and treatment percentages as 30%
and 10%. The parameters [β0, α0, α1, θG, θZ , θ1] are set to [0.3, 0.2, 0.4, 0.2, 0.2, 0.3].
Different values of θ0 are used to vary the censoring percentage. The vector [γ0, γ1]
was set to each of [1.5, 1.5], [1.5, 1.25] and [1, 1.5], to make φ1(t) = Λ01(t)/Λ00(t) a
constant, an increasing function and a decreasing function respectively. The prop-
erties of φ1(t) are studied at time t = 1, t = 2 and t = 3. Both the unstabilized
Wi(t) and stabilized W
S
i (t) are applied to the simulated data. We use the simplified
variance estimator which treats the IPCW weights as fixed; i.e., as given in (3.3).
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Tables 4.1, 4.2 and 4.3, show the results when the true ratio is increasing, de-
creasing and constant, respectively. All estimates are approximately unbiased. The
magnitude of the finite-sample bias generally increases as the sample size decreases.
There is no obvious association between the degree of bias and treatment percentage.
On one hand, one might expect that higher treatment percentages should increase
bias since the dependent censoring aspect figures move prominently in the estimat-
ing function. However, on the other hand, greater number of observed treatments
should generally result in modeling ΛTi (t) more precisely and hence to diminish the
bias. Generally, the average asymptotic standard error (ASE) is close to empiri-
cal standard error (ESE). The coverage probabilities (CP) with W Si (t) are generally
closer to 95% than those based on Wi(t). The CP tended to decrease as the sample
size decreased.
4.5 Application
We applied the proposed methods to ESLD patients initially placed on the wait
list for diseased donor liver transplantation between March 1, 2002 and December 31,
2009 in United States. Data were obtained from the Scientific Registry of Transplant
Recipients (SRTR). Only patients age ≥ 18 at listing were included in our study
sample, and we excluded retransplant candidates.
In order to construct the IPCW weight, a time-dependent stratified Cox model




where the subscript r = 1, . . . , 11 represents United Network for Organ Sharing
(UNOS) Region. The indicator Ai(t) reflects that patients do not contribute to the
estimation of θ0 or Λ
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list. The covariate, Zi(t), included MELD score, Status 1, albumin, age, gender,
race, diagnosis of Hepatitis C, body mass index, diabetes, hospitalization, blood
type, dialysis within prior week, encephalopathy, ascites and serum creatinine. We
used two types of weights Wi(t) and W
S
i (t). Even for the stabilized weight, some
extreme values existed. Since 99% of the estimated weights were less than 10, the
weights were then capped at 10.
The model of main interest (that for the wait list death hazard) is given by
λij(t) = λ0j(t) exp{β ′0Zi0},
where the subscript j = 0, . . . , 7 corresponding to Status-1 (j = 0; reference) and
MELD score (21-23, 24-26, 27-29, 30-32, 33-35, 36-40, >40). The baseline covariate
vector, Zi0, included terms representing albumin, age, gender, race, diagnosis, body
mass index, diabetes, hospitalization status, if dialysis within prior week, and previ-
ous malignancy. Although the MELD score is capped at 40 for allocation purposes,
in our analysis, calculated MELD scores over 40 were collected into a > 40 group.
A total of 66,884 subjects were eligible for our study. We focused on comparing
the MELD> 20 to Status 1 patients. The cumulative hazard ratio of high-MELD
patient to Status-1 patient are estimated up to 5 years. Restricting attention to
Status 1 and MELD> 20, the sample size was n = 16, 684.
Since the results with Wi(t) are similar to those with W
S
i (t), we only show the
stabilized version of hazard ratios. The estimated curves of hazard ratio, comparing
high-MELD to Status 1, are shown in Figure 4.1. Figures 4.2, 4.3 and 4.4 provide the
estimate together with the point-wise confidence interval for MELD> 40, MELD 36-
40 and MELD 21-23 versus Status-1 patients respectively. The curve of MELD> 40
patients is below the reference line of Status 1 in the short run; e.g., within 14
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Figure 4.1: Cumulative hazard ratio of high-MELD patients compared to Status 1
patients.
days. But afterward, the curve crosses the reference line and climbs to φ̂i(t) ≈ 3 and
remains flat for the remainder study follow-up. Other MELD categories have similar
curve patterns over time, but with different crossing times, varying from 14 to 250
days.
It is interesting that Status 1 patients have a lower mortality compared to high-
MELD patients. In practice, acute patients automatically lose their Status 1 desig-
nation after 14 days, since they are very likely to die within 2 weeks. In fact, it is
patients must apply to have their Status 1 classification re-certified after 7 days. It
is assumed that if they were ill enough the warrant Status 1 designation, they would
die within one week in the absence of a liver transplant. However, it appears that
a large portion of patients who were Status 1 at baseline live for years after wait
listing.
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Figure 4.2: Cumulative hazard ratio for MELD>40 patients compared to Status 1
patients, with 95% confidence interval.
Figure 4.3: Cumulative hazard ratio for MELD 36-40 patients compared to Status 1
patients, with 95% confidence interval.
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Figure 4.4: Cumulative hazard ratio for MELD 21-23 patients compared to Status 1
patients, with 95% confidence interval.
4.6 Discussion
In this article, we use the ratio of group-specific cumulative baseline hazard func-
tions as a time-dependent measure of the covariate-adjusted effect of group on mor-
tality. Under the target data structure, covariates are time-varying. The death
hazard model of interest adjusts for only time 0 covariates, such that death may
be dependently censored due to mutual correlation between the values of the time-
varying covariates (after time 0) with death an censoring times. IPCW is used to
obtain unbiased estimators, with a stabilized weight suggested. The fact that sub-
jects may experience time intervals of treatment-ineligibility is handled by fitting a
treatment hazard model that is conditional on being treatment-eligible, with a sub-
jects’s ineligible periods then zeroed out in the probability-of-remaining-untreated
calculation. Simulations show that the proposed methods work well in reasonable
sized samples. Finally, the proposed methods are applied in order to contrast liver
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wait list mortality between acute and chronic liver failure patients.
Very few comparisons between the mortality of Status 1 and high-MELD patients
have been carried out, primarily since it is generally assumed by the liver transplant
community that mortality is much higher for acute relative to chronic liver fail-
ure patients. However, based on a conventional time-dependent model and capping
follow-up at 14 days, Sharma et al. (2012) reported that wait list mortality for
high-MELD patients was very comparable with that of Status 1 patients. Moreover,
Sharma et al (2012) found that MELD≥ 40 was associated with significantly higher
two-week mortality than Status 1. The analysis in this chapter provides further
evidence that the prioritization for deceased-donor liver transplantation of Status 1
over MELD> 40 patients needs to be reconsidered.
Various methods related to those proposed in this chapter can be found in the
existing literature, although none estimate the quantity of interest under the as-
sumed data structure. In particular, Hernan, Brumback, and Robins (2000, 2001)
developed methods for estimating the average causal effect in terms of the hazard
ratio. Although the methods allow for treatment to be time-varying, proportional
hazards are assumed under the marginal structure model employed. Chen and Tsi-
atis (2001); Schaubel and Wei (2011); Zhang and Schaubel (2010) used restricted
mean survival time as a measure; such that the cumulative effect is captured. Each
of these methods estimates an average causal effect, which would be of interest in
many but not all settings. In many applications (such as out motivating example), a
conditional group effect is of greater interest. The estimator proposed in this Chap-
ter is analogous to that of Wei and Schaubel (2008), but allows for a richer covariate
structure and more general censoring patterns.
The motivating example considers treatment-free survival. It would be of interest
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to extend the proposed methods to estimate treatment effects.
CHAPTER V
Conclusion
In this dissertation, three novel semiparametric methods were developed for es-
timating the effect of either a longitudinal covariate or a time-dependent treatment
on survival. Each of the methods was motivated by issues in the analysis of liver
transplant data. The methods are intended for the analysis of observational data
and can accommodate dependent censoring.
In Chapter II, we developed semiparametric methods for estimating the effect of
a time-dependent covariate on treatment-free survival. The data structure of inter-
est consists of a longitudinal sequence of measurements and a potentially censored
survival time. The factor of chief interest is time-dependent. Treatment-free survival
iss of interest and is dependently censored by the receipt of treatment. A further
complication is that patients may be removed from consideration for treatment, ei-
ther temporarily or permanently. The proposed methods involve landmark analysis
and partly conditional hazard regression. Dependent censoring was overcome by a
variant of Inverse Probability of Censoring Weighting (IPCW). Application of the
proposed methods to national organ transplant registry data revealed that the sick-
est chronic end-stage liver disease patients have significantly greater pre-transplant
mortality than acute liver failure patients. The method may be challenging to apply
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to large data sets with long follow-up, due to computational intensity.
In Chapter III, we developed semiparametric methods for estimating the aver-
age difference between treatment-free and post-treatment restricted mean lifetime.
The underlying data structure was the same as in Chapter II, except that post-
treatment mortality was also considered. Methods from Chapter II were used to
model treatment-free survival. The post-treatment death hazard was modeled using
the time-dependent covariate history leading up to the treatment time. The average
treatment effect was obtained by averaging over treated subjects, in a manner which
accounts for the competing risks structure and the independent censoring of time to
treatment. Through the proposed methods, the mean survival benefit of deceased-
donor liver transplantation, based on 5-year restricted mean lifetime, was estimated
by Model for End-stage Liver Disease (MELD) score. The methods entail inverse
weights for each of the treatment and independent censoring time; with consistency
requiring the correctness of both such models.
In time to event data observed in medical studies, nonproportional hazards and
dependent censoring are common issues when comparing group-specific mortality.
The group effect on mortality might vary over time, as opposed to being constant.
In settings where the proportional hazard assumption fails, investigators tend to be
more interested in cumulative (as opposed to instantaneous) effects on mortality.
Therefore, in Chapter IV, we developed an estimator for the cumulative group effect
on survival in the presence of nonproportional hazards and dependent censoring. The
proposed estimator is based on the cumulative hazard function, assumed to follow a
stratified Cox model. No functional form need be assumed for the nonproportionality.
Through the proposed methods, it was revealed that acute liver failure patients have
lower pre-transplant survival than high-MELD patients, but only in the short-term.
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The use of stratification for the proposed methods provides much flexibility, but may
lead to instability for smaller data sets.
Each of the proposed methods was shown to be consistent and asymptotically
normal, with consistent covariance estimators provided. Simulation studies revealed





Appendix A: Proof of Theorem II.1
Appendix A: Proof of Theorem II.1
A.I. Notation
We begin by reviewing the essential notation:
i: subject (i = 1, . . . , n)
n: number of subjects
k: cross section (k = 1, . . . , K)
Di: death time for the ith subject
Ci: censoring time for the ith subject
Ti: treatment time for the ith subject
Xi = min(Di, Ci, Ti), observed time for the ith subject
Δi = I(Xi = Di)
ΔTi = I(Xi = Ti)
CSk: kth cross-section
Sik: follow-up time for ith subject at calendar date of the kth cross-section date
Ai(t): treatment eligibility indicator of ith subject at time t, Aik = Ai(Sik)
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Ãi(t) = {Ai(s); s ∈ [0, t)}: treatment eligibility history up to time t
Zi(t): time dependent covariate of the ith subject
Zik = Zi(Sik)
Z̃i(t) = {Zi(s); s ∈ [0, t)}: covariate history up to time t
Dik = Di − Sik, death time for the ith subject at date of the kth cross section
Tik = Ti − Sik, treatment time for the ith subject at date of the kth cross section
Cik = Ci − Sik, independent censoring time for the ith subject at date of the kth
cross section
β0: parameter coefficient of the death model
θ0: parameter coefficient of the treatment model
Death hazard; λik(t) = λ0k(t) exp{β ′0Zik}




In deriving the asymptotic properties of the proposed estimators the following con-
ditions are assumed for i = 1, ..., n and k = 1, ..., K
(a) {Xi, Δi, ΔTi , Z̃i(Xi), Ãi(Xi∧Ti)} are independent and identically distributed ran-
dom vectors.




λ0k(t)dt < ∞ and
∫ τ
0
λT0 (t)dt < ∞ where τ is the maximum follow-up time.
(d) Continuity of the following functions:
r
(1)





k (t; β, W ),
r
(2)









k (t; β, W ),where
r
(p)






is the limiting value of
R
(p)








for p = 0, 1, 2, with r
(1)
k (t; β, W ) and r
(2)
k (t; β, W ) bounded and r
(0)
k (t; β, W ) bounded
away from 0 for t ∈ [0, τ ] and β in an open set.
(e) Continuity of the following functions:
r
(1)
















T (t; θ), where
r
(p)
T (t; θ) = E[Ai(t)Yi(t)Zi(t)
⊗p exp{θ′Zi(t)}],
is the limiting value of
R
(p)






for p = 0, 1, 2, with r
(1)
T (t; θ) and r
(2)
T (t; θ) bounded and r
(0)
T (t; θ) bounded away from
0 for t ∈ [0, τ ] and θ in an open set.
(f) Positive-definiteness of the matrices ΩT (θ) and Ω(β), where




























k (t; β, W )
r
(0)
k (t; β, W )





zk(t; β, W ) = r
(1)
k (t; β, W )/r
(0)
k (t; β, W ),
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(g) P (Yik(t) = 1) > 0 for t ∈ [0, τk].
A.III. Outline of Asymptotic Derivation
We derive the influence functions of terms of interest as summations of indepen-
dent and identical distributed (i.i.d.) terms plus a term which converges to zero
in probability. Inverse weighting is involved in the below derivation and the proof
focuses on the Type C weight. The derivation consists of several parts in which the
quantities are approximated by a summation of i.i.d. terms.
1. n
1
2 (θ̂ − θ0)
2. n
1
2{Λ̂T0 (t) − ΛT0 (t)}
3. n
1
2{Λ̂Ti (t) − ΛTi (t)}
4. n
1
2{Ŵ Aik(t) − W Aik(t)}
5. n
1
2 (β̂ − β0)
A.IV. Derivation of Asymptotic Properties
Several parts of the proof regarding the proportional hazards model are well-
established results. Therefore, they are simply listed without proof. For details,
please refer to Anderson and Gill (1982), Fleming and Harrington (1991) and An-
dersen et al. (1993).
A.IV.1 n
1
2 (θ̂ − θ0)
As n → ∞, we have
n
1
2 (θ̂ − θ0) = ΩT (θ0)−1n− 12
n∑
i=1






{Zi(t) − z(t; θ)}dMTi (t; θ),
dMTi (t) = dN
T
i (t) − Yi(t)dΛTi (t),
A.IV.2 n
1
2{Λ̂T0 (t) − ΛT0 (t)}
We induce the following decomposition:
n
1
2{Λ̂T0 (t) − ΛT0 (t)}
= n
1
2{Λ̂T0 (t; θ̂) − ΛT0 (t; θ0)}(A.1)
+n
1
2{Λ̂T0 (t; θ0) − ΛT0 (t)}.(A.2)








{R(0)T (u; θ̂)−1 − R(0)T (u; θ0)−1}dNTi (u)













UTi (θ0) + op(1).
where the third line follows from the convergence in probability of










−1Z(u; θ)dNTi (u) = −
∫ t
0
Z(u; θ)dΛ̂T0 (u; θ),




















T (t; θ), to the quantities




and ΩT (θ) respectively, with ΩT (θ) defined in Regularity Condition (f).
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−1dMTi (u) + op(1),
where the second line follows from continuity and Condition (f). Combining results,
for the decomposition, we have
n
1





ΦTi (t; θ0) + op(1),
where
ΦTi (t; θ) = h
′












dΦTi (u; θ) = −z′(u; θ)dΛT0 (u)ΩT (θ)−1UTi (θ) + r(0)T (u; θ)−1dMTi (u).
A.IV.3 n
1
2{Λ̂Ti (t) − ΛTi (t)}
We begin with another decomposition,
n
1




































{eθ̂′Zi(u) − eθ′0Zi(u)}dΛ̂T0 (u).
By a Taylor series expansion,
n
1
2{eθ̂′Zi(u) − eθ′Zi(u)} = Z ′i(u)eθ
′Zi(u)n
1








UTl (θ) + op(1).
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Since Λ̂T0 (t)












UTl (θ) + op(1).



















dΦTl (u; θ0) + op(1).
Combining results from the decomposition leads to
n
1
2{Λ̂Ti (t) − ΛTi (t)} =
∫ t
0


















−1dMTl (u) + op(1)






























2{Ŵ Aik(t) − W Aik(t)}
When the subscript of quantities doesn’t involve the cross section notation k, t
refers the time from study entry. If k is present in the subscript, then t denotes the
time from cross section date.
Since W Aik(t) = e
ΛTi (t+Sik)−ΛTi (Sik) and Ŵ Aik(t) = e
Λ̂Ti (t+Sik)−Λ̂Ti (Sik), we then have
n
1
2{Ŵ Aik(t) − W Aik(t)}
= n
1
2{eΛ̂Ti (t+Sik)−Λ̂Ti (Sik) − eΛTi (t+Sik)−ΛTi (Sik)}
= W Aik(t)n
1


























2 (β̂ − β0)
It is straightforward to show that
n
1





AikUik(β0, Ŵ ) + op(1),
where we define
Uik(β, W ) =
∫ τk
0
{Zik − zk(t; β, W )}W Aik(t)dMik(t),

























































{Zik − zk(t; β, Ŵ )}{Ŵ Aik(t) − W Aik(t)}dMik(t)(A.7)
+op(1).
Now, through the Functional Delta Method, combined with a lot of tedious algebra,

























































UTl (θ) + op(1),
where the last equality follows from the convergence in probability of








{Zik − Zk(t; β, W )}W Aik(t)D′ik(t; θ)dMik(t),
to the quantity






{Zik − zk(t; β, W )}W Aik(t)D′ik(t; θ)dMik(t)
]
.


















{Zik − zk(t; β, W )}W Aik(t)dMik(t)
]



















G(u, τ ; β)r
(0)
T (u; θ)
−1dMTl (u) + op(1),
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where the last equality follows from the convergence in probability of










{Zik − Zk(t; β, W )}W Aik(t)dMik(t),
to the quantity







{Zik − zk(t; β, W )}W Aik(t)dMik(t)
]
.
Combining equations (A.5) (A.8) and (A.9), we obtain
n
1








{Zik − zk(t; β0, W )}W Aik(t)dMik(t)
+Ω(β0)














G(t, τ ; β0)r
(0)
T (t; θ0)















{Zik − zk(t; β0, W )}W Aik(t)dMik(t)
+H ′(t; β0, W )ΩT (θ0)−1UTi (θ0) +
∫ τ
Sik








Appendix B: Proof of Theorem III.1
Appendix B: Proof of Theorem III.1
B.I. Notation
We begin by reviewing the essential notation:
i: subject (i = 1, . . . , n)
n: number of subjects
k: cross section (k = 1, . . . , K)
Di: death time for the ith subject
Ci: independent censoring time for the ith subject
Ti: treatment time for the ith subject
Xi: min{Di, Ci}: observation time for the ith subject
Zi(t): covariate for ith subject at follow-up time t
Ai(t): treatment eligibility indicator of ith subject at time t
NTi (t) = I(Ti ≤ t, Ti < Xi); note that dNTi (t) = Ai(t)dNTi (t)
Z̃i(t) = {Zi(s); s ∈ [0, t)}: covariate history up to time t
Ãi(t) = {Ai(s); s ∈ [0, t)}: treatment eligibility history up to time t
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τ : pre-specified constant satisfying P (Xi ≥ τ) > 0 for all i.
Sik: follow-up time at calendar date of the kth cross section
Dik = Di − Sik, death time measured from date of kth cross section
Tik = Ti − Sik, treatment time measured from date of kth cross section
Cik = Ci − Sik, independent censoring time measured from date of kth cross section
Zi0k = Zi(Sik): covariate for subject i at date of kth cross-section
Ni0k(t) = Ni(Sik + t)I(Ti > Sik + t)
Aik = Ai(Sik)
τ0k: pre-specified constant satisfying P (Dik ∧ Tik ∧ Cik ≥ τ0k) > 0
Ni1(t) = I(Ti < Xi)Ni(Ti + t)
τ1: pre-specified constant satisfying P (Di − Ti ≥ τ1|Ti, Ti < Di) > 0
NCi (t) = I(Ci ≤ t, Ci < Di)
Treatment-free death hazard: λi0(t; Si) = λ00(t) exp{β ′0Zi0k}
Post-treatment death hazard: λi1(t; Ti) = λ01(t) exp{β ′1Zi(Ti)}
Treatment initiation hazard: λTi (t) = Ai(t)λ
T
0 (t) exp{θ′0Zi(t)}




In deriving the asymptotic properties of the proposed estimators the following con-
ditions are assumed for i = 1, ..., n and k = 1, ..., K
(a) {Xi, Δi, ΔTi , Z̃i(Xi), Ãi(Xi∧Ti)} are independent and identically distributed ran-
dom vectors.










λT0 (t)dt < ∞ and
∫ τ
0
λC0 (t)dt < ∞.
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(d) Continuity of the following functions:
r
(1)
















T (t; θ), where
r
(p)
T (t; θ) = E[Ai(t)Yi(t)Zi(t)
⊗p exp{θ′Zi(t)}],
is the limiting value of
R
(p)






for p = 0, 1, 2, with r
(1)
T (t; θ) and r
(2)
T (t; θ) bounded and r
(0)
T (t; θ) bounded away from
0 for t ∈ [0, τ ] and θ in an open set, with z⊗0 = 1, z⊗1 = z and z⊗2 = zz′ for a vector
z.
Continuity of the following functions:
r
(1)





0k (t; β, W ),
r
(2)





0k (t; β, W ),
and r
(0)
0k (t; β, W ), where
r
(p)






is the limiting value of
R
(p)










for p = 0, 1, 2, with r
(1)
0k (t; β, W ) and r
(2)
0k (t; β, W ) bounded and r
(0)
0k (t; β, W ) bounded
away from 0 for t ∈ [0, τ0k] and β in an open set.
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Continuity of the following functions:
r
(1)
















1 (t; β) where
r
(p)





is the limiting value of
R
(p)









for p = 0, 1, 2, with r
(1)
1 (t; β1) and r
(2)
1 (t; β1) bounded and r
(0)
1 (t; β1) bounded away
from 0 for t ∈ [0, τ1] and β1 in an open set.
Continuity of the following functions:
r
(1)



















C (t; α) = E[Yi(t)Zi(0)
⊗p exp{α′Zi(0)}],
is the limiting value of
R
(p)






for p = 0, 1, 2, with r
(1)
C (t; α) and r
(2)
C (t; α) bounded and r
(0)
C (t; α) bounded away from
0 for t ∈ [0, τ ] and α in an open set.
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(e) Positive-definiteness of the matrices ΩT (θ0), Ω0(β0), Ω1(β1) and ΩC(α0), where




























0k (t; β, W )
r
(0)
0k (t; β, W )





z0k(t; β, W ) = r
(1)
0k (t; β, W )/r
(0)









































(f) P{Yi(t) = 1} > 0 for t ∈ (0, τ ]
B.III. Outline of Asymptotic Derivation
We derive the influence functions of terms of interest as summations of indepen-
dent and identical distributed (i.i.d.) terms plus a term which converges to zero in
probability. The terms are as follows:
1. n
1
2 (θ̂ − θ0)
2. n
1
2{Λ̂T0 (t) − ΛT0 (t)}
3. n
1
2{Λ̂Ti (t) − ΛTi (t)}
4. n
1
2{Ŵ Aik(t) − W Aik(t)}
5. n
1







2{Λ̂i0(t; Si) − Λi0(t; Si)}
8. n
1












2{Λ̂i1(t; Ti) − Λi1(t; Ti)}
13. n
1






2 (α̂ − α0)
16. n
1
2{Λ̂C0 (t) − ΛC0 (t)}
17. n
1















2 (Δ̂ − Δ)
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B.IV. Derivation of Asymptotic Properties
Several parts of the proof regarding the proportional hazards model are well-
established results. Therefore, they are simply listed without proof. For details,
please refer to Anderson and Gill (1982), Fleming and Harrington (1991) and An-
dersen et al. (1993).
B.IV.1 n
1
2 (θ̂ − θ0)
As n → ∞, we have
n
1
2 (θ̂ − θ0) = ΩT (θ0)−1n− 12
n∑
i=1





{Zi(t) − z(t; θ)}dMTi (t; θ),
dMTi (t) = dN
T
i (t) − Yi(t)dΛTi (t),




2{Λ̂T0 (t) − ΛT0 (t)}
We induce the following decomposition:
n
1
2{Λ̂T0 (t) − ΛT0 (t)}
= n
1
2{Λ̂T0 (t; θ̂) − Λ̂T0 (t; θ0)}(B.1)
+n
1
2{Λ̂T0 (t; θ0) − ΛT0 (t)}.(B.2)
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{R(0)T (u; θ̂)−1 − R(0)T (u; θ0)−1}dNTi (u)













UTi (θ0) + op(1).
where the third line follows from the convergence in probability of








−1Z(u; θ)dNTi (u) = −
∫ t
0
Z(u; θ)dΛ̂T0 (u; θ),




















T (t; θ), to the quantities




and ΩT (θ) respectively, with ΩT (θ) defined in Regularity Condition (e).






















−1dMTi (u) + op(1),
where the second line follows from continuity and Condition (d). Combining results,
for the decomposition, we have
n
1





ΦTi (t; θ0) + op(1),
where
ΦTi (t; θ) = h
′













dΦTi (u; θ) = −z′(u; θ)dΛT0 (u)ΩT (θ)−1UTi (θ) + r(0)T (u; θ)−1dMTi (u).
B.IV.3 n
1
2{Λ̂Ti (t) − ΛTi (t)}
We begin with another decomposition,
n
1




































{eθ̂′Zi(u) − eθ′0Zi(u)}dΛ̂T0 (u).
By a Taylor series expansion,
n
1
2{eθ̂′Zi(u) − eθ′Zi(u)} = Z ′i(u)eθ
′Zi(u)n
1








UTl (θ) + op(1).
Since Λ̂T0 (t)












UTl (θ) + op(1).



















dΦTl (u; θ0) + op(1).
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Combining results from the decomposition leads to
n
1
2{Λ̂Ti (t) − ΛTi (t)} =
∫ t
0


















−1dMTl (u) + op(1)






























2{Ŵ Aik(t) − W Aik(t)}
Consistent with the notation set in Section B.I, when the subscript of quantities does
not involve the cross section notation k, t refers the time from study entry. If k is
present in the subscript, then t denotes the time from the kth cross section date.
Since W Aik(t) = e
ΛTi (t+Sik)−ΛTi (Sik) and Ŵ Aik(t) = e
Λ̂Ti (t+Sik)−Λ̂Ti (Sik), we then have
n
1
2{Ŵ Aik(t) − W Aik(t)}
= n
1
2{eΛ̂Ti (t+Sik)−Λ̂Ti (Sik) − eΛTi (t+Sik)−ΛTi (Sik)}
= W Aik(t)n
1


























2 (β̂0 − β0)
It is straightforward to show that
n
1







AikUi0k(β0, Ŵ ) + op(1),
where we define
Ui0k(β, W ) =
∫ τ0k
0
{Zi0k − z0k(t; β, W )}W Aik(t)dMi0k(t),

























































{Zi0k − z0k(t; β, Ŵ )}{Ŵ Aik(t) − W Aik(t)}dMi0k(t)(B.7)
+op(1).
Now, through the Functional Delta Method, combined with a lot of tedious algebra,





























































UTl (θ0) + op(1),
where the last equality follows from the convergence in probability of









{Zi0k − z0k(t; β, W )}W Aik(t)D′ik(t; θ0)dMi0k(t),
to the quantity






{Zi0k − z0k(t; β, W )}W Aik(t)D′ik(t; θ0)dMi0k(t)
]
.


















{Zi0k − z0k(t; β, W )}W Aik(t)dMi0k(t)
]



















G0(u, τ ; β)r
(0)
T (u; θ0)
−1dMTl (u) + op(1),
where the last equality follows from the convergence in probability of










{Zi0k − z0k(t; β, W )}W Aik(t)dMi0k(t),
to the quantity











Combining the equations (B.5) (B.8) and (B.9), we obtain
n
1










Aik{Zi0k − z0k(t; β0, W )}W Aik(t)dMi0k(t)




































2 [Λ̂00{t; Ŵ , R0(β̂0, Ŵ )} − Λ̂00{t; Ŵ , R0(β0, Ŵ )}](B.10)
+n
1
2 [Λ̂00{t; Ŵ , R0(β0, Ŵ )} − Λ̂00{t; W, R0(β0, Ŵ )}](B.11)
+n
1
2 [Λ̂00{t; W, R0(β0, Ŵ )} − Λ̂00{t; W, R0(β0, W )}](B.12)
+n
1
2 [Λ̂00{t; W, R0(β0, W )} − Λ00(t)](B.13)
































Z0(t; β, W ) = R
(1)
0 (t; β, W )/R
(0)
0 (t; β, W ).
R
(p)





0k (t; β, W ),
z0(t; β, W ) = r
(1)
0 (t; β, W )/r
(0)
0 (t; β, W ).
r
(p)





0k (t; β, W ),
h0(t; β, W ) = −
∫ t
0
z′0(u; β, W )dΛ00(u).














































JTikl(u; θ0)dNi0k(u) + op(1).(B.15)
Switching the order of summation, we have













UTl (θ0) + op(1),
where the last equality follows from the convergence in probability of




















































−1dMTl (u) + op(1),
where the last equality follows from the convergence in probability of














0 (u; β, W )
−1dNi0k(u),
to the quantity













Combining equations (B.14) and (B.15), we obtain





























W Aik(u){R(0)0 (u; β0, Ŵ )−1 − R(0)0 (u; β0, W )−1}dNi0k(u).
Now, through the Function Delta Method,
n
1
2{R(0)0 (u; β, Ŵ )−1 − R(0)0 (u; β, W )−1}








2{Ŵ Aik(u) − W Aik(u)}












{D′ik(u)ΩT (θ0)−1UTl (θ0) + JTikl(u)}
= R
(0)
0 (u; β, W )
























0 (u; β, W )




















−1dMTl (s) + op(1),
where the last line follows from the convergence in probability of












































0 (u; β0, W )



























×r(0)T (s, θ0)−1dMTl (s)dNi0k(u).
Switching the order of summation for the first term, and the order of summation
and integration in the second term, we have




































−1dMTl (u) + op(1),
where the last line follows from the convergence in probability of












0 (u; β, W )
2
dNi0k(u),









W Aik(u)Q0(t1, u; θ)
R
(0)






















W Aik(u)Q0(t1, u; θ)
r
(0)


































0 (u; β0, W )
dMi0k(u) + op(1),


























































0(t; β0, W )Ω
−1
0 (β0)Ui0(β0)



























2{Λ̂i0(t; Si) − Λi0(t; Si)}
We begin with another decomposition
n
1
2{Λ̂i0(t; Si) − Λi0(t; Si)}
= n
1
2{Λ̂i0(t, β̂; Si) − Λ̂i0(t, β0; Si)}(B.16)
+n
1
2{Λ̂i0(t, β0; Si) − Λi0(t)}.(B.17)































Combining equations (B.16) and (B.17), we obtain
n
1

















2{Ŝi0(t; Si) − Si0(t; Si)}
Using the Functional Delta Method and Result B.IV.7, we have
n
1







Si0(u; Si)du, where L is restricted time point. By continuity and






































For the second term, switching the order of integration and summation




















Combining equations (B.18) and (B.19), we have
n
1











































2 (β̂1 − β1)
It is straight forward to show that
n
1










{Zi1 − z1(t; β1)}dMi1(t),
dMi1(t) = dNi1(t) − Yi1(t)dΛi1(t).










2 [Λ̂01(t; β̂1) − Λ̂01(t; β1)](B.20)
+n
1
2 [Λ̂01(t; β1) − Λ01(t)](B.21)
























where the third line follows from the convergence in probability of

























and Ω1(β1) respectively, with Ω1(β1) defined in Regularity Condition (e).

























where the second line follows from continuity and Condition (d). Combining equa-

















































2{Λ̂i1(t; Ti) − Λi1(t; Ti)}
We begin with another decomposition
n
1
2{Λ̂i1(t; Ti) − Λi1(t; Ti)}
= n
1
2{Λ̂i1(t, β̂1; Ti) − Λ̂i1(t, β1; Ti)}(B.22)
+n
1
2{Λ̂i1(t, β1; Ti) − Λi1(t)}.(B.23)
Considering the first term, by a Taylor series expansion and Result B.IV.10, and
Λ̂01(t)






























Combining results from the decomposition leads to,
n
1


















2{Ŝi1(t; Ti) − Si1(t; Ti)}
Using the Functional Delta Method
n
1








Si1(u; Ti)du and where L is the restriction time point. By conti-
nuity and Result B.IV.12 and B.IV.13
n
1
2{μ̂i1(Ti) − μi1(Ti)} = n 12
∫ L
0































For the second term, switching the order of integration and summation
























Combining equations (B.24) and (B.25), we obtain
n
1


















































2 (α̂ − α0)
It is straightforward to show that
n
1
2 (α̂ − α0) = ΩC(α0)−1n− 12
n∑
i=1






{Zi(0) − zC(t; α)}dMCi (t; α),
dMi1(t) = dNi1(t) − Yi1(t)dΛik(t).
This is now a well-established Cox model result, derived through Martingale theory.
B.IV.16 n
1
2{Λ̂C0 (t) − ΛC0 (t)}
We start the following decomposition
n
1
2{Λ̂C0 (t) − ΛC0 (t)}
= n
1
2{Λ̂C0 (t; α̂) − Λ̂C0 (t; α0)}(B.26)
+n
1
2{Λ̂C0 (t; α0) − ΛC0 (t)}.(B.27)






















UCi (α0) + op(1),
where the third line follows from the convergence in probability of





































and ΩC(α) respectively, with ΩC(α) defined in Regularity Condition (e).
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−1dMCi (u) + op(1),
where the second line follows from continuity and Condition (d). Combining equa-
tions (B.26) and (B.27), for the decomposition, we have
n
1





ΦCi (t; α0) + op(1),
where














dΦCi (u; α) = −zC(u; α)dΛC0 (u)ΩC(α)−1UCi (α) + r(0)C (u; α)−1dMCi (u).
B.IV.17 n
1
2{Λ̂Ci (t) − ΛCi (t)}
We start with another decomposition,
n
1












Λ̂Ci (t; α) − ΛCi (t)
}
.(B.29)
Considering the first term,
(B.28) = Λ̂C0 (t)n
1
2{eα̂′Zi(0) − eα′0Zi(0)}.
By a Taylor series expansion,
n
1












UCj (α0) + op(1).
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As Λ̂C0 (t)
p−→ ΛC0 (t) for t ∈ [0, τ ], we obtain









UCj (α0) + op(1).













dΦCj (u; α0) + op(1).
Combining result leads to
n
1
2{Λ̂Ci (t) − ΛCi (t)} =
∫ t
0




























































i (t) and Ĝi(t)
−1 = eΛ̂
C
i (t), we then have
n
1

























From Result B.IV.8 and B.IV.13, we have
n
1
2{Ŝi0(t; Ti) − Si0(t; Ti)} = −Si0(t; Ti)n 12{Λ̂i0(t; Ti) − Λi0(t; Ti)} + op(1),
n
1
2{Ŝi1(t; Ti) − Si1(t; Ti)} = −Si1(t; Ti)n 12{Λ̂i1(t; Ti) − Λi1(t; Ti)} + op(1),






2{Ŝi1(t; Ti) − Si1(t; Ti)} − n 12{Ŝi0(t; Ti) − Si0(t; Ti)} + op(1)
= Si0(t; Ti)n
1








ϕSij(t) = Si0(t){Λi0(t)Zi(Si)′Ω−10 (β0)Uj0(β0) − eβ
′
0Zi(t)Φj0(t)}









ŜΔi(u)du and Δi(t) =
∫ t
0
SΔi(u)du, and Result B.IV.19, we have
n
1












where switch the integration and summation sign, we obtain
n
1
2{Δ̂i(t) − Δi(t)} = n− 12
n∑
j=1





























= P (Ti ≤ t, Ti < Di) = V (τ).
Then by Slutsky’s Theorem, we can write







−1dNTi (u) + op(1).



















































































{SΔi(t; u) − SΔ(t)}Gi(u)−1dNTi (u) + op(1).(B.32)
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V1j(t) + V2j(t) +
∫ τ
0










ξj(t) = V (τ)
−1
{
V1j(t) + V2j(t) +
∫ τ
0









ŜΔ(t)dt and Δ =
∫ L
0
SΔ(t)dt, we can have
n
1










Figure B.1: Estimated post- and pre-transplant survival curves for all MELD groups
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APPENDIX C
Appendix C: Proof of Theorem VI.1
Appendix C: Proof of Theorem IV.1
C.I. Notation
We begin by reviewing the essential notation:
i: subject (i = 1, . . . , n)
j: strata (j = 0, 1, . . . , J − 1)
Di: death time for ith subject
Ci: censoring time for ith subject
Ti: treatment time for ith subject
Xi = min{Di, Ci, Ti}: observation time for ith subject
Δi = I(Xi = Di)
ΔTi = I(Xi = Ti)
Ai(t): treatment eligibility indicator of ith subject at time t
Zi(t): covariate for ith subject at follow-up time t
Zi0 = Zi(0): covariate for ith subject at follow-up time t = 0
Z̃i(t) = {Zi(s); s ∈ [0, t)}: covariate history up to time t
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Ãi(t) = {Ai(s); s ∈ [0, t)}: treatment eligibility history up to time t
Gi: group variable for ith subject
Yi(t) = I(Xi ≥ t)
Yij(t) = Yi(t)I(Gi = j)
β0: regression parameter, death model
θ0: regression parameter, treatment model
Death baseline hazard: λij(t) = λ0j(t) exp{β ′0Zi0}




In deriving the asymptotic properties of the proposed estimators the following con-
ditions are assumed for i = 1, ..., n and j = 0, ..., J − 1
(a) {Xi, Δi, ΔTi , Z̃i(Xi), Ãi(Xi)} are independent and identically distributed random
vectors.




λ0j(t)dt < ∞ and
∫ τ
0j
λT0 (t)dt < ∞ where τ is the maximum follow-up time.
(d) Continuity of the following functions:
r
(1)





j (t; β, W ),
r
(2)





j (t; β, W ),
and r
(0)
j (t; β, W ), where
r
(p)





is the limiting value of
R
(p)








for p = 0, 1, 2, with r
(1)
j (t; β, W ) and r
(2)
j (t; β, W ) bounded and r
(0)
j (t; β, W ) bounded
away from 0 for t ∈ [0, τ ] and β in an open set.
(e) Continuity of the following functions:
r
(1)
















Tj (t; θ), where
r
(p)
Tj (t; θ) = E[Yij(t)Zi(t)
⊗p exp{θ′Zi(t)}],
is the limiting value of
R
(d)






for p = 0, 1, 2; with r
(1)
Tj (t; θ) and r
(2)
Tj (t; θ) bounded and r
(0)
Tj (t; θ) bounded away from
0 for t ∈ [0, τ ] and θ in an open set.
(f) Positive-definiteness of the matrices ΩT (θ) and Ω(β), where






























j (t; β, W )
r
(0)
j (t; β, W )





zj(t; β, W ) = r
(1)
j (t; β, W )/r
(0)
j (t; β, W ).
(g) P (Yi(t) = 1) > 0 for t ∈ [0, τ ].
126
C.III. Outline of Asymptotic Derivation
The proof below focuses on the unstabilized weight. We derive the influence
functions of various terms of interest as summations of independent and identically
distributed (i.i.d.) terms plus a term which converges to zero in probability. The
terms are as follows:
1. n
1



















C.IV. Derivation of Asymptotic Properties
Asymptotic Normality:
Some parts of the proof regarding the proportional hazards model are results
well-established. Therefore, they are simply listed without proof. For details, please





2 (θ̂ − θ0)
As n → ∞, we have
n
1










{Zi(t) − xj(t; θ)}dMTij (t; θ),
dMTij (t) = dN
T
ij (t) − Yij(t)dΛTi (t),










2{Λ̂T0j(t; θ̂) − ΛT0j(t; θ0)}(C.1)
+n
1
2{Λ̂T0j(t; θ0) − ΛT0j(t)}.(C.2)








{R(0)Tj (u; θ̂)−1 − R(0)Tj (u; θ0)−1}dNTij (u)

















UTij (θ0) + op(1).
where where the third line follows from the convergence in probability of







































Tj (t; θ), to the quantities






and ΩT (θ) respectively, with ΩT (θ) defined in Regularity Condition (f).






















−1dMTij (u) + op(1),
where the second line follows from continuity and Condition (f). Combining results,
for the decomposition, we have
n
1





ΦTij(t; θ0) + op(1),
where



























































By a Taylor series expansion,
n
1
















































dΦTlj(u; θ0) + op(1).
Combining result from the decomposition, then we have
n
1
2{Λ̂Tij(t) − ΛTij(t)} =
∫ t
0




















−1dMTlj (u) + op(1)

































As Wi(t|Gi) = exp{ΛTiGi(t)} and Ŵi(t|Gi) = exp{Λ̂TiGi(t)}, we have
n
1
2{Ŵi(t) − Wi(t)} = n 12{exp{Λ̂TiGi(t)} − exp{ΛTiGi(t)}}
= Wi(t)n
1





















It is straight forward to show that
n
1





Uij(β0, Ŵ ) + op(1),
where
Uij(β, W ) =
∫ τ
0
{Zi0 − zj(t; β, W )}Wi(t)dMij(t),




















































{Zi0 − zj(t; β, Ŵ )}{Ŵi(t) − Wi(t)}dMij(t) + op(1).(C.7)
Now, through the Functional Delta Method, combined with a lot of tedious algebra,


































































where the last equality follows from the convergence in probability of







{Zi0 − zj(t; β, W )}Wi(t)D′iGi(t; θ0)dMij(t),
to the quantity





{Zi0 − zj(t; β, W )}Wi(t)D′iGi(t; θ0)dMij(t)
]
.



































































Combining equations (C.5) (C.8) and (C.9), we obtain
n
1










{Zi0 − zj(t; β, W )}Wi(t)dMij(t)
+H ′(t; β, W )ΩT (θ)−1
J−1∑
j=0










2 [Λ̂0j{t; Ŵ , Rj(β̂, Ŵ )} − Λ̂0j{t; Ŵ , Rj(β0, Ŵ )}](C.10)
+n
1
2 [Λ̂0j{t; Ŵ , Rj(β0, Ŵ )} − Λ̂0j{t; W, Rj(β0, Ŵ )}](C.11)
+n
1
2 [Λ̂0j{t; W, Rj(β0, Ŵ )} − Λ̂0j{t; W, Rj(β0, W )}](C.12)
+n
1
2 [Λ̂0j{t; W, Rj(β0, W )} − Λ0j(t)](C.13)



























hj(t; β, W ) = −
∫ t
0
z′j(u; β, W )dΛ0j(u).
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Switching the order of summation, we obtain


















where the last equality follows from the convergence in probability of








j (u; β, W )
−1Wi(u)D′iGi(u)dNij(u)
to the quantity






















where the last equality follows from the convergence in probability of







































Combining equations (C.14) and (C.15), we have
























Wi(u){R(0)j (u; β0, Ŵ )−1 − R(0)j (u; β0, W )−1}dNij(u).
Now through the Function Delta Method,
n
1
2{R(0)j (u; β, Ŵ )−1 − R(0)j (u; β, W )−1}




























j (u; β, W )
















Q̂′l(s, u; θ0) + op(1)
= R
(0)
j (u; β, W )
















Q′l(s, u; θ0) + op(1),
where the last line follows from the convergence in probability of



















































j (u; β0, W )





















Switching the order of summation for the first term, and the order of summation
and integration in the second term, we have



























Plj(u; β0) + op(1),
where the last equality follows the convergence in probability of









j (u; β, W )
2
dNij(u),



























































j (u; β0, W )
dMij(u) + op(1).


















































j(t; β0, W )Ω
−1(β0)Ui(β0)














































{Λ̂0j(t) − Λ0j(t)} − Λ̂0j(t)
Λ200(t)
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